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Substance use disorder (SUD) is one of the major unresolved health problems 
affecting contemporary societies. According to the updated Diagnostic and Sta-
tistical Manual of Mental Disorders SUD is a brain disease in which psycho-
active drug(s) evoke clinically significant distress or social or occupation impair-
ments. In the current classification of both substance use and dependence the 
following criteria are included: craving, abuse, tolerance, withdrawal, continued 
used despite health problems. Craving is defined as a strong urge or desire to 
use the substance. Withdrawal is exhibited by either (1) a person having charac-
teristic withdrawal symptoms for the specific substance or (2) a person using a 
substance or one closely related to it to avoid the substance-specific withdrawal 
symptoms. The substance classes are based on their mechanism of action: alco-
hol, cannabis, caffeine, hallucinogens, inhalants, opioids, sedatives-hypnotics-
anxiolytics, stimulants, tobacco and others (Administration, 2016). 
The use of biomarkers would aid in making SUD diagnoses, unfortunately 
none are used due to lack of suitability. Drugs or their metabolites in body 
fluids, hair or breath are present only during a short time period after an acute 
use, the replicated genetic variants are rare in many populations and the 
specificity of brain imaging techniques is still under development, thus, bio-
markers are not yet appropriate for use in diagnosis making and need further 
research (Hasin et al., 2013). 
Currently there is no causal treatment for SUD. Addictive drugs change 
various brain systems that are not yet well understood. They have a reinforcing 
effect by activating the mesolimbic dopamine pathway where drugs usurp 
synaptic plasticity processes. Moreover, addictive drugs also induce neuro-
adaptations between other neurotransmitter and hormone systems and changes 
in gene transcription and function that are partly mediated by epigenetic 
mechanisms. These adaptations also affect stress responsivity. Therefore, a 
better understanding of the contribution of various basic mechanisms to the 
transition from drug use to abuse furthers the development of effective 




1. Reward learning and incentive motivation 
Numerous philosophical and psychological studies have been performed to 
answer the question “what motivates us to act? “. Generally, it is understood 
that a reward will prompt us to obtain an incentive, whereas a punishment will 
motivate us to avoid it. Reward is defined as “an event that increases the 
probability of a response with a positive hedonic component” (Koob and Volkow, 
2016). A neutral stimulus (conditioned stimulus) can be paired with a natural 
reward and a drug reward (unconditioned stimulus) to motivate behavior 
(Siegel, 1979). The behavioral response can be directed towards the outcome or 
towards the conditioned stimulus. Some have thought that the goal-oriented 
learning can explain all motivated behaviors (Donahoe et al., 1997), however, 
other studies have shown evidence of another form of learning, instrumental or 
operant learning (Konorski, 1948). Instrumental actions are either (1) performed 
to acquire a reward through an association created with a stimulus that predicts 
the reward or (2) since there is no understanding or the causal relationship 
between the action and the outcome, action evaluation becomes irrelevant and 
instrumental actions are only dependent on the adjoining of the action and the 
reward. Therefore, instrumental behavior under certain circumstances can shift 
from goal-oriented behavior to stimulus-reward oriented behavior, in which 
environmental stimuli that have been paired with an action that obtains a 
reward, trigger the instrumental action. This performance is said to be under 
habitual control and in this case, the outcome does not motivate behavior 
directly, but the stimuli-reward actions are strengthened by the outcome. 
Numerous studies have shown that animals need learn about the increased value 
of an instrumental outcome and with increased amount of training, the action 
selection shifts from goal-directed to habitual behavior. Thus, the drug-seeking 
behavior increases due to the enhanced incentive value of the drug (Hutcheson 
et al., 2001). 
 
 
2. Theories of drug addiction 
The concept of addiction can be explained as a three-stage periodically 
repeating circle that worsens over time and involves neuroplastic modifications 
in the brain reward, stress and executive function systems (Koob and Volkow, 
2016). The three stages comprise of binge/intoxication, withdrawal/negative 
effect, and preoccupation/anticipation (craving). Different reinforcements affect 
and drive the recurring circle, positive reinforcement of the binge/intoxication 
stage, negative reinforcement to avoid adverse emotional state (dysphoria, 
anxiety, irritability) when access to the drug is prevented and the positive and 
negative conditioned reinforcement associated with the preoccupation/anti-
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cipation stage (Koob and Moal, 2001). Impulsivity is defined as “a predisposi-
tion toward rapid, unplanned reactions to internal and external stimuli without 
regard for the negative consequences of these reactions to themselves or others” 
and is accompanied by feelings of pleasure, gratification (Moeller et al., 2001). 
Compulsivity manifests as “perseverative, repetitive actions that are excessive 
and inappropriate” and in obsessive-compulsive disorder are carried out to 
reduce anxiety and tension from obsessive thoughts (Berlin and Hollander, 
2014). Impulsivity and compulsivity drive drug-taking behavior at different stages 
of the addiction cycle and in the context of addiction, individuals shift from 
impulsivity to compulsivity (Koob and Volkow, 2016).  
The drug seeking and self-administration behaviors can be understood with 
these two underlying concepts – conditioned reinforcement and incentive 
salience. Drugs of abuse have a thorough effect on previously neutral stimuli 
and can be coupled with them. The phenomenon, called conditioned reinforce-
ment, is defined as when a previously neutral stimulus strengthens certain 
behaviors through its association with drug of abuse and becomes a reinforcer 
itself (Koob and Volkow, 2016). The motivation for rewards coming from both 
one’s physiological state and previously learned associations about a reward cue 
is defined as incentive salience and is mediated by the mesocorticolimbic 
dopamine system (Koob and Volkow, 2016). The ability of conditioned cues to 
recruit reward circuits and increase the progression through the addiction cycle 
helps to explain the intensity of the desire for the drug (craving) and the 
compulsive use even when the pharmacological effects weaken (Koob and 
Volkow, 2016).  
Several theories have been developed to explain how recreational drug use 
transitions into compulsive drug seeking, in which the individual continues to 
use it, because of the feeling of need, despite serious negative consequences and 
reduced pleasure. According to the incentive motivation theory, chronic drug 
use results in persistent alterations in the neural circuitry associated with 
stimulating motivation that allows drugs and their cues to enhance drug-seeking 
behavior (Robinson and Berridge, 1993).  
 
 
3. Brain reward system 
Many studies have linked dopamine (DA) with reward behavior. The brain 
reward system was first described by Olds and Milner in 1954, where they 
showed that rats learned to work inexhaustibly to receive or avoid an intra-
cranial electrical stimulation of specific septal nuclei, described as rewarding or 
aversive (Olds and Milner, 1954). DA was identified to maintain brain stimu-
lation in medial prefrontal cortex (PFC), nucleus accumbens (NAc, a part of 
ventral striatum), ventral tegmental area (VTA) (Phillips and Fibiger, 1978). In 
agreement with these studies, DA receptor antagonists (Franklin and McCoy, 
1979) and lesions in dopaminergic regions reduce self-stimulation behavior 
(Strecker et al., 1982). Overactivation of the DA system, however downregulates 
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the DA receptors and repeated drug intake decreases the importance of alternative 
stimuli (Volkow et al., 2017) 
Natural rewards and addictive drugs alike are able to increase synaptic DA in 
the NAc via dopaminergic neurons in the VTA. The NAc is mainly composed 
(>90%) of medium spiny neurons classified by their expression of different DA 
receptors (Mews et al., 2018). Fast and steep increases of DA is associated with 
the subjective sensation of the so-called “high” (Hyman et al., 2006; Volkow et 
al., 2003). The fast and steep augmentation of DA is mediated by low-affinity 
D1 receptors (via increased cAMP signaling), which are necessary for reward 
and cue-induced reponses (Caine et al., 2007). D3 receptors that co-localize with 
D1 receptors in the NAc are also associated with drug-seeking behavior (Vorel et 
al., 2002). Slower DA signaling is associated with motivated behaviors and 
incentive motivation (Berridge, 2007; Schultz, 2002). D2 receptors, in contrast, 
are not necessary for drug reward (Caine et al., 2002).  
The neurocircuitry that is associated with drug reward has been broadened to 
include projections that interact with the basal forebrain and other neurotrans-
mitters and neuromodulators (Koob and Volkow, 2016, 2010). The neurons in 
the PFC are regulated by DA activity through D1 and D2 receptors and send a 
glutamatergic projection to the NAc. The aforementioned glutamatergic 
projection to the NAc among others is associated with drug reinstatement. 
Blockade of DA receptors in the PFC reduced cocaine-induced reinstatement; 
while conversely, DA injections to the PFC elicit a reinstatement of cocaine self-
administrative behavior (McFarland and Kalivas, 2001). Furthermore, drug 
administration can trigger synaptic changes in glutamatergic projections from 
the prefrontal cortex and amygdala to the VTA and NAc (Egervari, 2016). 
Glutamate receptors include NMDA ionotropic receptors that modulate cell 
excitability. Grin1 encodes a critical subunit for proper NMDA channel function. 
Thus, repeated drug use impairs the capacity of PFC to regulate cocaine-seeking 
habits due to dysregulation in glutamate signaling. 
 
 
4. Neurobiology of drug addiction 
4.1. Primary neurobiological targets of psychostimulants and  
brain adaptations to long-term psychostimulant use 
Addiction is a state in human behavior manifested by compulsive drug use 
despite serious negative consequences (Hyman et al., 2006). Drug addiction can 
be defined as a chronic relapsing disorder of compulsive drug use and loss of 
control over drug intake despite serious negative consequences (Hyman et al., 
2006; Koob and Volkow, 2016). An important goal of current neurobiological 
research is to understand the changes at the molecular, cellular and neuro-
circuitry levels of the transition from occasional and controlled drug taking to 
loss of control in drug use, dependence and the way how these changes persist 
in the vulnerability to relapse (Koob and Moal, 2001).  
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Psychostimulants increase DA neurotransmission in the NAc, their primary 
mechanism of action is either blocking the DA transporter (cocaine) or directly 
increasing DA efflux (amphetamine) (McCreary et al., 2015). Psychostimulants 
have several primary targets including DA, noradrenaline (NA) and serotonin  
(5-HT) transporters. There can be several mechanisms of action among different 
psychostimulants. For example, amphetamine is a monoamine transporter inhi-
bitor (via trace amine-associated receptor 1 agonism) and releases DA, NA,  
5-HT from synaptic vesicles via vesicular monoamine transporter 2 and dys-
functions DA metabolism by inhibiting monoamine oxidase (McCreary et al., 
2015). However, the reinforcement properties of cocaine-like drugs correlate 
with their affinity to DA but not to NA or 5-HT receptors (Ritz et al., 1987).  
Cocaine and other psychostimulants cause long-term drug-induced changes 
on molecular, cellular and behavioral level (Nestler, 2013; Paulson et al., 1991). 
For transcriptional and epigenetic changes to affect the behavior in addiction, it 
must change some functional output, such as neuronal excitability (intrinsic 
membrane properties) or connectivity (synapse number or strength). Psycho-
stimulants also affect neuronal connectivity; the effect is most clearly seen on 
the changes in number, shape and size on medium spiny neurons in NAc (Russo 
et al., 2010). 
Altered signal transduction and gene expression are thought to mediate the 
cellular and behavioral adaptations that drugs induce and sustain (Nestler, 2013; 
Nestler and Aghajanian, 1997). The causal role of cAMP (cyclic adenosine 
monophosphate) pathway-CREB (cAMP response element binding protein) 
upregulation in tolerance and dependence has gathered substantial support in 
recent decades (Nestler, 2016). Chronic administration of opiates and stimulants 
upregulates cAMP formation, cAMP-dependent protein kinase A (PKA) activa-
tion and PKA-dependent protein phosphorylation in the nucleus accumbens 
(NAc) (Nestler, 2016; Terwilliger et al., 1991). Drug-seeking behavior refers to 
patient’s manipulative and demanding behavior with the aim of obtaining the 
drug. Self-administrating animals display drug-seeking behavior by persistant 
learned response (lever pressing) when drug is unavailable. Various interventions 
of cAMP/PKA signaling pathway have shown to increase drug self-adminis-
tration or enhance drug-seeking behavior (Edwards and Koob, 2010; Self et al., 
1998). Thus, the upregulation of cAMP/PKA pathway in NAc may be an 
important neuroadaptation for the establishment and maintenance of the 
addicted state. 
The best studied transcription factors that are activated by drugs of abuse are 
CREB, ∆FosB, NF-κB and Nr3c1 alias GR (the latter will be discussed in the 
following chapters), which in turn activate target genes and specific behavioral 
aspects of addiction. CREB is a major cAMP-regulated transcription factor. 
CREB serves to reduce an animal’s sensitivity to the rewarding effects of the 
drug (tolerance) in NAc and mediates the negative emotional state during 
withdrawal (Barrot et al., 2002; DiNieri et al., 2009). These manifestations drive 
increased drug self-administration (Larson et al., 2011). The effect of CREB 
overexpression in NAc medium spiny neurons helped to limit behavioral 
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sensitivity to cocaine and thus by decreasing the reinforcing value of natural 
and drug rewards, cAMP-CREB upregulation contributes to the decrease in 
reward pathway and to the negative emotional state in withdrawal (Dong et al., 
2006; Koob and Volkow, 2016). CREB-mediated transcription increases in 
NAc response to chronic stress, while knockdown of CREB leads to opposite 
phenotype, thus CREB is also involved in stress susceptibility and depression-
like behavior (Barrot et al., 2002; Covington et al., 2011). 
Repeated substance use increases transcription factor ∆FosB levels per-
sistently that has been demonstrated with many drugs of abuse (Nestler, 2008). 
It has also been shown in human addicts (Robison et al., 2013). The behavioral 
phenotype of ∆FosB overexpressing animals resembles rodents after chronic drug 
administration. For example, in response to acute and chronic cocaine adminis-
tration mice show increased locomotor activity (Kelz et al., 1999). The mice 
also show enhanced sensitivity to rewarding effects in place-conditioning assays 
and ∆FosB increases self-administration of the very low doses of cocaine, 
apparently through a process of positive reinforcement (Colby et al., 2003; Kelz 
et al., 1999). 
Nuclear factor-κB (NF-κB) is a transcription factor activated by various 
intra- and extracellular stimuli, previously characterized by its functions in the 
immune system. NF-κB has been recently associated with synaptic plasticity 
and memory by being activated by basal synaptic input through a pathway 
requiring Ca2+/ calmodulin-dependent kinase and local Ca2+ elevation (Meffert 
et al., 2003).  
NF-κB expression is induced after chronic cocaine administration in the NAc 
and this is necessary but not sufficient for sensitization to the drug’s rewarding 
effects (Russo et al., 2009). NF-κB has a role in medium spiny neuron spino-
genesis in stress models which is particularly interesting considering the pheno-
menon of stress induced relapse to addiction (Christoffel et al., 2011).  
 
 
4.2. Animal models in psychostimulant research 
Understanding the neurobiology of addiction has been acquired through animal 
models and brain imaging studies of individuals with addiction. Animal models 
permit investigations of specific phenomena associated with the human patho-
logical state such as models of genetic, epigenetic, cellular, transcription and net-
work systems; symptoms like craving, relapse, depressive-like state and others 
(Koob and Volkow, 2016).  
The modern neuropsychopharmacological studies of drug addiction began in 
1962, when the rat intravenous drug self-administration procedure was devel-
oped (Weeks, 1962). Animal models aim to resemble the human condition (face 
validity) and to possess explanatory power of the pathology (construct validity). 
Additionally, animal models should predict the pharmacological potential of a 
compound in humans or a variable dependent of drug addiction. Drugs of abuse 
and the drug-associated stimuli have a powerful reinforcing effect. Animal 
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models of drug abuse include non-contingent (experimenter-administered) and 
contingent (self-administered) drug delivery. Behavioral sensitization is measured 
after repeated non-contingent drug treatments, whereas the recent contingent 
studies mostly focus on the reinstatement of drug-use or drug-seeking behavior. 
Both model types assess the effect of repeated drug use to neural function, but 
differ by drug administration. 
Sensitization is defined as an enhanced response to a stimulus after a repeated 
exposure to that stimulus (Steketee and Kalivas, 2011). Behavioral sensitization 
is manifested as an increased psychomotor response that occurs with repeated 
and intermittent drug exposure by inducing dopaminergic pathways. Psycho-
stimulant-induced behavioral sensitization models addictive behaviors, namely 
those associated with craving, relapse and psychotic complications of psycho-
stimulant abuse in rodents (J.-F. Chen et al., 2003; Robinson and Berridge, 
1993). Motor activity is commonly monitored and repeated exposure increases 
the motor-stimulant response. However, sensitization with higher doses of 
amphetamine can escalate to stereotypic behavior that interferes with loco-
motion (Leith and Kuczenski, 1982). The environment of drug administration 
can be paired with drug acquisition and thus influence sensitization. Many studies 
have shown that repeated psychostimulant administration in the same environ-
ment as previous drug exposure can enhance behavioral sensitization (Steketee 
and Kalivas, 2011). Behavioral sensitization can also be measured by condi-
tioned place preference (CPP) or drug self-administration. Sensitization in the 
CPP paradigm is exhibited as an increased time spent in psychostimulant-
associated environment. 
Repeated administration of psychostimulants to rodents causes an enhanced 
locomotor response to subsequent drug injection, a phenomenon known as 
behavioral sensitization that can be divided into induction and expression phase 
of sensitization (Pierce and Kalivas, 1997; Robinson and Berridge, 1993). 
Initiation phase shows the immediate neural effects induced by drug exposure, 
while expression is the long-term consequences of initial events. Initiation is 
commonly associated with the ventral tegmental area and expression is linked to 
NAc.  
In the self-administration studies, rodents acquire the drug by performing a 
behavioral response (pressing a lever) that is a sign of the drug’s reinforcing 
properties. In the most commonly used fixed ratio schedules, the number of 
responses required for a dose infusion is set as a constant number and a certain 
minimum dose is required for stable behavioral responding. Drug infusion is 
signaled by an environmental stimulus that becomes a conditioned stimulus for 
the drug. Drug self-administration models show stable responding during various 
sessions and the response can be changed predictably by neurotransmitter 
antagonists. 
In the human condition, abstinence occurs often voluntarily and due to adverse 
consequences of drug use and relapse is triggered by the reinforcing properties 
of drug-associated stimuli (reviewed in Kõks, 2015). Newer preclinical self-
administration models are emerging that can also distinguish various psycho-
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logical constructs of the disorder that facilitate compulsive relapse after 
voluntary abstinence and thus are focused on assessing the motivational and re-
inforcing value of drug-associated stimuli (Belin-Rauscent et al., 2016). In this 
“incubation of craving” method, longer abstinence periods result in increased 
drug-seeking behavior when reintroduced to the drug-associated environment 
that resembles the human phenomenon of increased craving after prolonged 
abstinence. To date, this version of the self-administration model in rodents is 
regarded as the most translational to the human condition (Lax and Szyf, 2018). 
Current animal models have face validity (resembles the human condition) 
and some construct validity (has explanatory capacity) in three different stages 
of addiction. Psychopathologies and stress may influence human drug-seeking 
behavior, but animal studies showed that these pre-existing conditions are not 
necessary for drugs to be rewarding (Kõks, 2015). Moreover, self-adminis-
tration of addictive drugs by laboratory animals supports understanding that 
drugs are universal reinforcers and human-specific factors are not necessary for 
reinforcement to take place (Kõks, 2015). Thus, both contingent and non-
contingent models have construct validity for drug intoxication.  
Animal models have greatly contributed to the knowledge of the molecular 
targets and neuroadaptations occurring after acute and chornic drug exposure 
place (Kõks, 2015). Both the behavioral sensitization and the self-adminis-
tration have construct validity at the drug reinstatement phase in that they seem 
to correctly predict the neurocircuitry of substance abuse (Steketee and Kalivas, 
2011). The “incubation of craving” model has provided a new possibility to 
study an additional human aspect of increased craving behavior after prolonged 
abstinence. The disharmony of animal and human studies likely indicates that 
the latter are influenced by additional factors not duplicated in animal studies or 
from subject/experimenter biases.  
 
 
5. Activity-dependent drug induced neuroplasticity 
The term neural plasticity has been in use in brain sciences for more than a 
century to refer to the changes in neural organization that would explain the 
modifiability of behavior, including short- or long lasting behavior, forms of 
learning and adaptability in response to injury. The fundamental mechanism of 
behavioral modifiability is attributed to synaptic transmission between neurons, 
whereby existing pathways are strengthened or new ones formed. The outcome 
of this process leads to structural (anatomical/morphological), functional (physio-
logical) and biochemical changes in the brain (Berlucchi and Buchtel, 2009). 
The modifiability of synapses to store information on a long-term basis involves 
synapse-to-nucleus signaling pathways. New mRNA and protein synthesis to 
provide substrates for alterations in the synapse is seen as a requirement to store 
information / stabilize experiences. This synaptic activity-dependent tran-
scription is distinguished from the basal gene expression. Thus, animal studies 
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have revealed that the basis of cognitive functions such as learning is synaptic 
activity-driven transcriptional mechanism (Yap and Greenberg, 2018). 
Neurotransmitter-induced genomic response requires an influx of cytoplasmic 
calcium by stimulation of ligand-gated ion channels, such as the NMDA gluta-
mate receptors and voltage-sensitive calcium channels or by the release of 
calcium from intracellular stores. The increase in cytoplasmic calcium leads to 
the activation of Ras-mitogen-associated protein kinase, calcium/calmodulin-
dependent protein kinases, and calcineurin-mediated signaling pathways that 
mediate local alterations in synapses and also induce the activity-controlled 
transcription factors. These include CREB, myocyte enhancer factor 2 (MEF2), 
and the serum response factor (SRF) and induce the expression of immediate 
early genes (IEG) that are defined as “a class of genes that are rapidly and 
transiently induced by extracellular stimuli, without a requirement of new 
protein synthesis”. IEGs, such as Fos, regulate a delayed response of gene 
expression of many genes related to cellular processes, such as dendritic growth, 
synapse formation, maturation and elimination, excitatory-inhibitory balance of 
circuits, as well as neuronal metabolic homeostasis and survival (Yap and 
Greenberg, 2018). 
Activity-regulated DNA methylation-based priming mechanisms have been 
proposed to allow a permissive genomic state through recurring activity for a 
healthy neuronal transcriptome (Pruunsild and Bading, 2019). An alternative 
isoform of DNA methyltransferase 3A (Dnmt3a), that is Dnmt3a, is upregulated 
by synaptic activity and may be a central regulator for maintaining the tran-
scriptomic profile (Oliveira et al., 2012). DNMT3A enzyme activity is 
associated with cocaine seeking, and its expression is altered during withdrawal 
(LaPlant et al., 2010; Massart et al., 2015). Besides the role of DNMT3A2 in 
experience-dependent behavior, the role of DNMT3A2 cocaine-related behavior 
was recently elucidated (Cannella et al., 2018).  
Drug addiction can be viewed as a dysfunctional neural plasticity in indi-
viduals induced by repeated drug use. Roughly 50% of the risk to drug addiction 
can be attributed to genetic contribution. Genome-wide studies have identified 
numerous genes with changed expression in rodent and primate models of 
addiction and human addicts (Albertson et al., 2006a; Freeman et al., 2001; 
Zhou et al., 2011). For example, in the human NAc, opioid peptide prodynorphin 
increases in cocaine addicts (Albertson et al., 2006b) that has been established 
on animal models previously and dynorphin may counteract the resposes of over-
stimulated dopamine system. Candidate-gene driven approaches have revealed a 
number of single nucleotide polymorphisms that were associated with cocaine 
addiction. These polymorphisms were located near L-type calcium channel 
CACNA1D, cannabinoid receptor 1, delta opioid receptor (Pierce et al., 2018). 
Some results have been replicated, but not all and perhaps the abovementioned 
can be considered as targets for novel drug development. 
Other genome-wide studies have identified first risk genes for cocaine 
dependence and only few have been replicated, such as rs16969968 in the 
CHRNA5 gene and rs806368 in CNR1 (Bühler et al., 2015). The association 
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between both CHRNA5 and CNR1 and cocaine addiction was protective (Bühler 
et al., 2015). A missense polymorphism rs16969968:G > A in nicotinic acetyl-
choline receptor α-5 subunit is strongly associated as a nicotine risk gene 
(Bühler et al., 2015) and because both cocaine and nicotine and frequently co-
abused, the polymorphism was studied also in cocaine addiction. However, the 
association between the polymorphism in nicotinic α-5 subunit and cocaine 
abuse was found to be protective for cocaine addiction (Grucza et al., 2008). 
The physiological basis of this finding is unknown, but contributes to the idea 
that common genetic factors underlie drug abuse. The risk factors that con-
tribute the other half include adverse early life experiences (discussed below) 
and other environmental stimuli that render the individual more vulnerable to 
drug exposure (Peña et al., 2013). Neurons activated during drug-associated 
learning require distinct profiles of gene expression in key brain areas involved 
in the reward circuit. Epigenetic mechanisms that underlie normal cellular and 
synaptic functioning are viewed as mediators both in addiction vulnerability and 
in drug-induced maladaptations in the brain. 
Some genome-wide studies have been performed to examine DNA methyla-
tion changes with expression analysis after neuronal activity (Guo et al., 2011a; 
Halder et al., 2016). Differentially methylated and expressed genes in the hippo-
campus were functionally categorized under “ion channels” and “transcriptional 
regulation” (Halder et al., 2016). Thus, DNA methylation is thought to regulate 
synaptic transmission and gene transcription critical for memory maintenance 
(Oliveira, 2016) and that could include drug-associated memories. DNA methyla-
tion seems to induce stable changes in drug-associated memory genes (Bayraktar 
and Kreutz, 2018). Neurons activated during learning require distinct profiles of 
gene expression. Epigenome is seen as a signal integration platform through 
which environment interacts with an individual’s genome to integrate new 
information in the service of the stable neuronal functioning.  
 
 
6. Epigenetic mechanisms 
6.1. Basic mechanisms of epigenetic modifications 
While the “central dogma” of the transcription of genetic information from DNA 
to RNA and subsequent translation into proteins remains a guiding principle in 
gene expression, the field of epigenetics was developed to explain the inter-
action of genome to external stimuli to stabilize cell phenotype (Crick, 1970). 
Epigenetics can be defined as “the study of any potentially stable and, ideally, 
heritable change in gene expression or cellular phenotype that occurs without 
changes in Watson-Crick base-pairing of DNA” (Goldberg et al., 2007). DNA 
is packed into chromosomes through highly regulated organizations to allow the 
selective accessibility of transcription machinery to specific genomic elements 
(including promoters, enhancers, silencers, open reading frames, insulators etc). 
Epigenetic processes comprise of chemical (modifications on DNA and histone 
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proteins) and structural alterations (chromatin remodeling and inter/intra-
chromosomal DNA-DNA interactions) that enable a long-term regulation of 
gene function and hence influence cell lineage, function and fate (Chen et al., 
2017a).  
The human genome of more than 3 billion base pairs of DNA is compacted 
400,000-fold to fit into the nuclear volume of ~1000 µm3 (Schneider and Gros-
schedl, 2007). Histones are the main proteins used to coil the DNA to form 
nucleosomes, the basic repeating structural unit. Nucleosomes contain about 
146 bp of DNA and an octamer of histones composed of two of each histone 
monomer (H2A, H2B, H3, and H4). Histones are positively charged in the N 
terminus (enriched with arginine and lysine residues) that facilitates the binding 
to the negatively charged DNA molecule. The nucleosomes are further pack-
aged into higher-order structures of chromatin fibers and chromosomes (Chen et 
al., 2017a). Yet, the compacted genetic information remains accessible to tran-
scriptional and repair mechanisms also due to numerous modifications on the  
N-terminal tail of histones and on DNA that increase histone-DNA contacts to 
promote transcriptional repression and vice versa. It is well known that 
chromatin structure and nuclear organization have major roles in regulating 
gene expression during development and abnormal functioning of the cell 
(Cremer et al., 2006; Schneider and Grosschedl, 2007).  
 
 
6.2. Histone tail modification and noncoding RNAs 
One form of epigenetic information includes more than 130 posttranslational 
modifications of histones, including acetylation, methylation, phosphorylation, 
ubiquitylation and sumoylation that correlated with promoters and gene bodies. 
Each modification of histones can change the accessibility of DNA and recruit 
transcription factors and coactivators/corepressors to various genomic regions 
(e.g. promoters, genme bodies, enhancers) to activate or silence transcription. 
Posttranslational modifications also interact with DNA methylation. The infor-
mation can be actively erased (e.g. lysine demethylases and deacetylases), but 
passive copying during cell division is currently less clear (Chen et al., 2017a). 
Another layer of information is provided by noncoding RNAs (ncRNAs) that 
are not translated into proteins and can be distinguished by their size (e.g. small 
ncRNAs, microRNAs), for example long ncRNAs (lncRNAs) are more than 
200 bases in length. lncRNAs are classified according to their genomic loci or 
associated DNA strands into sense, antisense, intronic, intergenic, enhancer, or 
circular RNAs. lncRNAs are characterized by the lack of an open reading frame, 
shorter encoded RNA sequences, relatively low expression levels in comparison 
with mRNAs. lncRNAs are localized mostly in the nucleus and they are pro-
duced in a cell type, tissue and developmental stage specific manner (Chen et 
al., 2017a). An example of lncRNA-mediated silencing is the X chromosome 
inactivation in female mammals. The hallmarks of X chromosome silencing are 
reorganization of the chromosomal architecture, recruitment of repressor 
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complexes, modification of histones, methylation of CpG islands and others that 
lead to remarkable folding on an entire chromosome in each cell, exclusion of 




6.3. DNA methylation and demethylation 
DNA methylation is an epigenetic mechanism that allows for a long-term adapt-
ability of gene expression in response to developmental or environmental signals. 
DNA methylation comprises of a covalent addition of a methyl group at the 5th 
carbon of cytosine and predominantly occurs at cytosine-phosphate-guanine 
(CpG) dinucleotides (Chen et al., 2017b). 5-methylcytosine (5-mC) in the mam-
malian genome is involved in numerous biological functions (e.g. embryonic 
development, monoallelic expression of imprinted genes, X-chromosome-inac-
tivation in female cells, repression of transposable elements, cancer, regulation 
of transcription) (Bird, 2002). Methylation signals are interpreted by tran-
scription factors or by methylated-DNA-binding proteins (also known as readers, 
e.g. methyl-CpG binding protein 2, MeCP2) that affect further biological 
processes. DNA methylation of CpGs in promoter regions usually results in 
suppression of downstream gene expression by recruiting co-repressor complexes 
that repress transcription (Lin et al., 2007). However, the methylation of 5’-up-
stream, gene body, and 3’-downstream CpGs has been associated with tran-
scriptional activation in various cell types, including neurons (Mo et al., 2015a). 
It is speculated that transcription factors could recruit other factors to change 
the status of heterochromatin to euchromatin and readers may affect splicing 
regulation during transcription (Meehan et al., 1989; Zhu et al., 2016). Cytosine 
methylation at non-CpG sites has also been reported, including in mature 
neurons, however, the function and mechanisms of this type of methylation are 
not yet elucidated (Jang et al., 2017; Lister et al., 2013). Therefore, we are 
beginning to understand how the transcriptional outcome of DNA methylation 
is affected by the genomic location of the methyl mark. 
DNA methylation can be mediated by different DNA methyltransferases 
(DNMT), including complexes and some of them are associated with non-
specific DNA sequences, while others are targeted to specific loci (Hervouet et 
al., 2018). DNA methylation is processed by the DNMT family of enzymes, 
subdivided into three classes: DNMT1, DNMT2 and the DNMT3A/3B/3L/3C. 
DNMT1 recognizes hemimethylated CpG sites on newly synthesized DNA 
during replication and methylates the daughter-strand cytosine at the comple-
mentary CpG, thus providing a way for passing epigenetic information through 
cell generations (Bostick et al., 2007; Sharif et al., 2007). New sites of DNA 
methylation are inserted by de novo DNA methyltransferases DNMT3A and 
DNMT3B and it occurs on both strands independently of DNA replication 
(Chen et al., 2017a). Recently discovered DNMT3C is a catalytically active 
enzyme and was previously annotated as a pseudogene (Barau et al., 2016). 
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DNMT3L is a structural protein and lacks the methyltransferase domain, but is 
required for gene imprinting and the regulation of DNMT3A/3B. DNMT3L and 
DNMT3C are linked to reproduction: DNMT3L stimulates germ line genome-
wide methylation and DNMT3C methylates evolutionally young retrotran-
sposons during spermatogenesis (Barau et al., 2016; Bourc’his and Bestor, 2004). 
The methylation of both strands can be achieved more effectively through 
the cooperation of DNMT3 enzymes with DNMT1 in post-mitotic neurons 
(Feng et al., 2010). The interaction between DNMT1 and DNMT3A/B has been 
shown to be necessary in HEK-293 cells, thus there is evident crosstalk between 
maintenance and de novo methylation machineries (Kim et al., 2002). The 
functions of DNMT2 (renamed as tRNA aspartic acid methyltransferase 1 by 
the HUGO Gene Nomenclature Committee) have been poorly studied, it is 
mainly involved in the methylation of specific tRNAs that links its role to post-
transcriptional gene regulation and protein translation (Goll et al., 2006; Lyko, 
2018; Okano et al., 1998). This expands our knowledge of the regulatory capa-
cities of the DNMT family. 
The modification can be removed, either passively during cell division or by 
enzyme-mediated reactions coupling with base excision repair that result in un-
methylated cytosine. Ten-eleven translocation (TET) methylcytosine dioxy-
genases together with thymine DNA glucosylase (TDG) form the capabilities 
for oxidation and removal of 5-mC. TET enzymes catalyze the oxidation of  
5-mC to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-fC) and  
5-carboxylcytosine (5-caC), and in vitro studies suggest that TET enzymes can 
use various combinations of substrates, including 5-hmC, 5-fC, 5-caC paired 
with 5-mC on the complementary strand (Chen et al., 2017a). Subsequently, a 
DNA repair protein, thymine DNA glycosylase (TDG) by hydrolyzing the 
carbon-nitrogen bond between the sugar-phosphate backbone of DNA and the 
mispaired thymine prepares the substrate for removal and replacement with an 
unmethylated cytosine by the base excision repair system (Maiti and Drohat, 
2011; Weber et al., 2016). TET-mediated demethylation is involved in develop-
ment, embryonic stem cell maintenance and differentiation, neuronal functions 
and cancer (Wu and Zhang, 2017).  
 
 
6.4. Neuronal functions of DNA methylation and  
TET-mediated demethylation 
DNMT1, DNMT3A/3B/3L are mutated in diverse human syndromes, those 
affecting neuronal functions will be discussed further. Dominant, heterozygous 
mutations of DNMT3A in the germ line causes Tatton-Brown-Rahman syndrome 
(OMIM 602769), characterized by tall stature, a distinctive facial appearance 
and intellectual disability and although there is no methylation data yet 
available, it is thought that a disruption of normal expression of imprinted genes 
is involved in this syndrome. DNMT3A de novo mutations have been identified 
in some individuals with autism spectrum disorder (Sanders et al., 2015). Germ 
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line origin, dominant mutations of DNMT1 cause a heterogeneous group of adult-
onset neurological disorders that include cerebellar ataxia, sensorineural deafness, 
narcolepsy, dementia, and other neurological and psychiatric abnormalities 
(OMIM 126375 and 605712). Methylation abnormalities are likely to be 
involved in the cause of all DNMT-affected conditions and the specific loci 
involved remain to be defined in the future (Edwards et al., 2017). 
Relatively few functions of DNMT have been elucidated in the central 
nervous system (CNS). A constitutive Dnmt1 and Dnmt3b knockout in the CNS 
is lethal and the knockout of Dnmt3a results in early postnatal death in mice 
(Fan et al., 2001; Li et al., 1992; Okano et al., 1999). Dnmt1 regulates the survival 
of retinal and cortical interneurons and the impairments in γ-aminobutyric acid 
(GABA)-ergic neurotransmission have also been reported in the patho-
physiology of different CNS diseases like schizophrenia and autism suggesting 
a role of Dnmt1 in the regulation of cell death (Symmank and Zimmer, 2017).  
Several reports have studied the neuronal phenotype on Dnmt knockdown 
mice. Feng and colleagues induced a conditional deletion of Dnmt1 and Dnmt3a 
in excitatory postnatal neurons (specifically in neurons expressing calcium/ 
calmodulin-dependent protein kinase IIα) in the mouse forebrain (Feng et al., 
2010). In their previous studies, single gene deletions of Dnmt1 or Dnmt3a in 
the mouse brain did not cause any gross abnormalities in brain structures or 
DNA methylation levels in repetitive elements, therefore they hypothesized that 
Dnmt1 and Dnmt3a may compensate for each other. The deficiency of DNMT1 
and DNMT3A in forebrain neurons impairs the long-term potentiation and 
long-term depression in the hippocampus and causes spatial learning and 
memory deficits and no such alterations were seen in single gene knockout mice 
(Feng et al., 2010). However, a more recent report indicated that Dnmt1 and 
Dnmt3a cannot replace each other, as spatial and novel object recognition and 
conditioned taste aversion learning impairments as well as long-term potentiation 
alterations were seen in forebrain-specific single knockout of Dnmt3a, but not 
of Dnmt1 (Morris et al., 2014). Thus, specific deficits in learning were associated 
with the loss of Dnmt3a, but not Dnmt1, suggesting that DNMT3A is involved 
in certain types of learning and memory that are distinct from DNMT1. The 
reason for discrepancies between two aforementioned reports is unclear, but 
differences in the sex and age of subjects may have contributed to these findings. 
Both DNMT1 and DNMT3A were associated with affective disorders. 
Dnmt3a overexpression induced a depressive-like behavior in the NAc, but in 
the PFC Dnmt3a overexpression decreased anxiety, while Dnmt3a knockdown 
in the PFC caused anxiogenic effects (E. Elliott et al., 2016; LaPlant et al., 
2010). Thus, it seems that Dnmt3a knockdown has opposing effects in the PFC 
vs. NAc on anxiety and depressive-like behavior. Moreover, deletion of Dnmt1 in 
the postnatal forebrain neurons resulted in anxiolytic effects in contrast with 
Dnmt3a deletion in the PFC (E. Elliott et al., 2016; Morris et al., 2016). Thus, 
DNMT1 and DNMT3A may have contrasting effects in some behavioral 
paradigms and future studies can clarify the region-specific roles on anxiety- and 
depressive-like behavior. 
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TET proteins have been shown to have various roles in the nervous system.  
5-hmC (5-hydroxymethylcytosine) is highly abundant in various subtypes of 
neurons, suggesting that stem cells and neurons may be particularly susceptible 
to changes in DNA methylation state (Kriaucionis and Heintz, 2009; Münzel 
et al., 2010). Many studies have shown that neuronal activity induces DNA 
demethylation (Chen et al., 2003; Guo et al., 2011b, 2011a; Lubin et al., 2008; 
Ma et al., 2009; Martinowich et al., 2003; Miller and Sweatt, 2007). Repeated 
cocaine administration downregulates TET1 in NAc, alters 5-hmC distribution 
and the expression of differentially spliced isoforms (Feng et al., 2015). Tet1 
knockout mice have impaired hippocampal neurogenesis, abnormalities in 
learning and memory, and synaptic plasticity, along with the downregulation of 
several neuronal-activity-induced genes in the hippocampus (Rudenko et al., 
2013; Zhang et al., 2013). TET1 overexpression results in transcriptional and 
behavioral changes that may be independent of its catalytic activity (Kaas et al., 
2013). TET proteins may function independently of their catalytic functions by 
recruiting or repelling other factors (Wu and Zhang, 2017). TET2 functions are 
relatively unexplored, but seems to be involved in adult neurogenesis in the 




7. DNA methylation in psychostimulant-induced 
neuroplasticity 
DNMT and TET enzymes both play a role in cocaine abuse in reward-related 
brain regions, such as the NAc, prefrontal cortex, amygdala, and the VTA 
(Kalda and Zharkovsky, 2015; Lax and Szyf, 2018). Chronic cocaine treatment 
altered the expression of Dnmt3a, but not other DNMT enzymes (LaPlant et al., 
2010). Furthermore, DNMT3A had a negative regulation effect on cocaine 
reward in the NAc, authors showed that inhibition of DNMT3A increased and 
overexpression decreased reward-like behavior in rats (LaPlant et al., 2010). 
Further studies have elucidated the drug-seeking behaviors and neural adapta-
tions in drug addiction with chronic cocaine treatment. Methionine is a methyl 
group donor that increases general DNA methylation levels, treatment with 
methionine during chronic cocaine exposure attenuated behavioral response to 
cocaine, including self-administration and Dnmt3a and Dnmt3b specifically 
increased in the NAc independently of methionine treatment (Wright et al., 
2015). Methionine may have a specific effect on psychostimulant reward 
behavior, as no behavioral differences were observed with natural rewards 
(Wright et al., 2015). Cue-induced cocaine seeking behavior decreased with 
RG108 treatment after short abstinence from cocaine and the behavioral effect 
endured up to 1 month (Massart et al., 2015). Conversely, SAM (S-adenosyl 
methionine) treatment had an increasing effect on cocaine seeking lasting up to 
1 month (Anier et al., 2013; Massart et al., 2015). These results imply that DNA 
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methylation is essential to cue-induced cocaine seeking after an abstinence 
period. Cocaine also increases MeCP2 expression in the dorsal striatum and the 
protein knockdown in this region inhibits cocaine self-administration (Im et al., 
2010), indicating that DNA methylation-mediated repression of gene expression 
generally blunts the drug abuse-like behavior. 
DNA methylation is involved in long-term changes in gene expression 
induced by psychostimulants (Anier et al., 2010; Han et al., 2010; LaPlant et al., 
2010). Further evidence of DNA methylation in psychostimulant abuse comes 
from studies on specific gene promoters. First studies have begun to elucidate also 
the genome-wide changes in methylation patterns (Feng et al., 2015; Massart et 
al., 2015). Massart and colleagues studied the status of methylation marks over 
prolonged withdrawal period and their analysis showed that some marks remain 
stable and others are enhanced, while abstinence progressed (Massart et al., 
2015). Increased 5-hmC after cocaine exposure at intron-exon boundaries was 
correlated with alterations in global gene expression. The results indicated that 
cocaine induced changes in exonic 5-hmC enrichment could regulate alternative 
splice site usage (Feng et al., 2015). 
 
 
8. Drugs affecting DNA methylation 
Azanucleosides (AZN) are pyrimidine analogues that are considered the first 
epigenetic drugs. 5-azacytidine (azacitidine) and 5-aza-2’-deoxycytidine (decit-
abine) are used for the treatment of acute myeloid leukemia and myelodys-
plastic syndromes. Both drugs are known to have two main mechanisms of 
antitumor activity. First, they cause cytotoxicity due to incorporation into DNA 
(azacitidine is incorporated into DNA as well as into RNA) and lead to DNA 
damage response. Secondly, AZN lead to DNA hypomethylation by irreversible 
inhibition of DNMT, mostly DNMT1. DNMT1 recognizes the incorporated 
cytidine analogue as a natural substrate and binds to it irreversibly inhibiting 
DNA methyltransferase function during replication and is therefore degradated. 
Consequently, methylation marks are lost and hypomethylation in silenced 
tumor suppressor genes leads to their reactivation and restoration of normal cell 
growth and differentiation in tumor cells. AZN act as DNA demethylating drugs 
at lower doses and are cytotoxic at higher doses, the latter limiting also dose 
regimens at the clinic due to unacceptable toxicity against normal cells (Diesch 
et al., 2016). Molecular targets of AZN include DNA demethylation of the 
promoter of silenced tumor suppressor genes, e.g. a key gene in cell cycle 
regulation p15, and downregulation of overexpressed metabolic genes. The ratio 
of cytidine deaminase (CDA) to deoxycytidine kinase (DCK) was higher in 
decitabine responders compared to non-responders (Qin et al., 2011) suggesting 
that increased deamination and decreased phosphorylation of the drug may be 
the mechanism of primary resistence. However, not all studies identify 
demethylation in a tumor suppressor gene and the correlation between the levels 
of DNA demethylation and clinical responses to decitabine have not been 
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clearly established. Several factors contribute to this discrepancy, such as 
elimination of demethylated clones, clonal replacement by resistant cells and 
others. Azacytidine was first approved for the treatment of myelodysplastic syn-
dromes in 2004 by the US Food and Drug Administration (Raynal and Issa, 
2016). 
AZN have poor chemical stability in solution and are sensitive to enzymatic 
degradation, thus zebularine and a dinucleotide, guadecitabine, were synthesized 
for improved aqueous stability. Zebularine has a weak DNMT inhibition activity, 
but due to toxicity in primates the clinical trials were blocked. Guadecitabine 
(SGI-110) is composed of decitabine and guanosine linked with a phos-
phodiester bond that has shown improved DNA demethylation activity and a 
prolonged half-life as compared to decitabine (Raynal and Issa, 2016). SGI-110 is 
currently under evaluation in clinical trials across multiple cancer types 
including advanced solid tumors (www.clinicaltrials.gov).  
Non-nucleosidic inhibitors were developed to overcome the toxicity and 
non-specificity of nucleosidic compounds, such as RG108 which directly blocks 
the active site of DNMT1. RG108 has a significantly longer half-life in aqueous 
solution compared to 5-azacitidine (~20 days versus 17 hours). Moreover, 
RG108 does not cause covalent DNMT trapping in human cell lines which is 
associated with lower levels of toxicity in comparison with AZN (Brueckner et 
al., 2005). RG108 is highly lipophilic, but safe for in vivo use, therefore it is 
currently assessed at the preclinical stage (Schneeberger et al., 2016). 
 
 
9. Early life stress triggers predisposition and  
vulnerability to drug addiction 
9.1. Stress and cocaine addiction 
Several preclinical and clinical studies have shown that exposure to early life 
stress is a major risk factor for the development of various adult psychopatho-
logies including drug dependence (Enoch, 2011). Early life stress causes 
chronic activation of the hypothalamus-pituitary-adrenal (HPA) axis, morpho-
logical adaptations and transcriptional changes in the DA reward circuitry that 
are all associated with the development of drug abuse. Furthermore, many 
studies show a correlation between child’s neurodevelopmental disturbances 
and maternal stress and anxiety during pregnancy (Glover, 1997; Koss and 
Gunnar, 2018). Some pre- and early postnatal studies in humans have pointed to 
differential DNA methylation in multiple cortisol regulatory genes (Koss and 
Gunnar, 2018). 
Central control of glucocorticoid release is regulated by a population of 
neurosecretory neurons in the hypothalamic paraventricular nucleus (PVN). 
Stress triggers the release of two neuropeptides from these neurons, corti-
cotrophin-releasing hormone (CRH) and arginine vasopressin. The subsequent 
increases in adrenocorticotropin (ACTH) from the anterior pituitary stimulate 
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the adrenal cortex synthesis and release of cortisol in humans, and corti-
costeroids in rodents, that can directly send negative feedback to the PVN. 
During prolonged or intense stressors the input to the PVN can override the 
negative feedback and continue corticosteroid secretion. In the brain, gluco-
corticoids exert their action through mineralocorticoid (MR) and glucocorticoid 
receptors (GR). MR has high and GR has low affinity to glucocorticoids, thus 
GR bind at the peak of the daily rhythm and as well as glucocorticoid levels rise 
during an acute stressor. Acute HPA axis responses are necessary on functioning, 
however, under chronic stress, a dysregulation of the axis occurs that leads to 
elevated plasma corticosterone levels (Herman and Cullinan, 1997). Chronic 
stress can cause neuronal exitotoxicity leading to reduction of dendritic morpho-
logy in the hippocampus that modulates the stress response (Magariños et al., 
1996). Glucocorticoids upon binding to GR form homo- or heterodimers and 
bind glucocorticoid response elements (GRE) in target genes to regulate their 
transcription (Oakley and Cidlowski, 2013). Negative GREs have been described, 
where GR after binding recruits corepressors and GR can also influence target 
gene transcription indirectly by interfering with upstream signaling pathways of 
other transcription factors (Oakley and Cidlowski, 2013).  
Postnatal environment influences HPA axis activity. The postnatal period in 
rodents coincides with the stress hypo-responsive period during the first 2 
weeks of life, while the baseline plasma glucocorticoid levels are lower than 
normal (Levine, 1994). Nevertheless, one of the most potent stressors for pups 
is the separation from the dam. Maternal separation (MS) is an animal model of 
chronic stress, where rat pups are separated from the mothers and littermates for 
long periods (3 hours or more) per day for several subsequent days from PND3 
to PND20. MS induces molecular and functional changes in GABA receptors 
and CRH, and in repeated prolonged MS (360 min), alterations in glutamate 
receptors (Miczek et al., 2008). MS leads to an increased HPA activity by 
increased plasma ACTH and corticosterone (CORT) secretion and a decrease of 
growth hormone, whereby they lose weight (Kuhn et al., 1990). MS rats also 
display decreased hippocampal GR binding and increased hypothalamic CRH 
mRNA in adulthood (Plotsky and Meaney, 1993; Vázquez et al., 1996). Brief 
handling of pups (10–15 min per day) decreases HPA responses to stressors 
encountered in adulthood that may be related to the increased expression of GR 
in the hippocampus and prefrontal cortex (Meaney et al., 1996).  
Exposure to stress at a young age in humans is associated with an increased 
risk to drug abuse. Depression has been associated with the dysregulation of the 
HPA axis (Bruijnzeel et al., 2004; Rao et al., 1999). Epidemological studies 
show high prevalence in both depression and SUD and also indicate a high 
comorbidity between these diseases (Bruijnzeel et al., 2004; Kessler et al., 
1994). In cocaine-dependent individuals, higher lifetime stress was positively 
correlated with addiction severity (Mahoney et al., 2013). These studies 
implicate a role of HPA axis dysregulation on drug abuse behavior, although the 
causal relationship remains unclear. Experimental evidence support the idea that 
stress reactivity is altered in drug abusers, although CRF antagonists have not 
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been found effective in the treatment of drug addiction (Fosnocht and Briand, 
2016). Thus, stress in early life can affect vulnerability to drug addictive 
behavior in later life. 
Many studies have described the potential role of GR in initiating cocaine-
induced neuroplasticity. The putative neural circuit for stress-induced cocaine 
use includes of dopaminergic projections to the PFC from the VTA (Mantsch et 
al., 2014). Many other stress- and drug-cue related inputs converge on the VTA 
as a key integration site. The glutamate projections from PFC to the NAc core 
that form part of the mesocortical pathway have been implicated for stress-
induced reinstatement (McFarland et al., 2004). However, other clinical and 
preclinical reports show that stressors themselves do not directly trigger cocaine-
seeking behavior, but rather function as increasing reactivity to drug related cues 
(Mantsch et al., 2014). 
GR is expressed in many neurons that comprise the stress-induced cocaine 
seeking circuit, including the stress responsive neurons in the PFC (Ostrander 
et al., 2003) and GR regulation of stress-responsive processes has been demon-
strated in these brain regions. In the PFC, chronic stress induces reorganization 
in the dendritic morphology (Cook and Wellman, 2004) and blocking GR 
locally in the PFC reduces stress-induced dopaminergic signaling efflux (Butts 
et al., 2011). The glutamatergic neurotransmission from the PFC to the NAc has 
also been shown to be regulated by GR (Campioni et al., 2009). The role of GR 
in establishing and reinforcing effects of cocaine has also been examined on the 
behavioral level. Whole brain GR knock-out reduced behavioral sensitization 
and a GR antagonist weakens the motivation to self-administer cocaine (Deroche-
Gamonet et al., 2003). Selective deletion of GR in dopaminergic neurons in the 
NAc decreases cocaine-induced behavioral sensitization (Barik et al., 2010), 
while overexpression of GR in the PFC increases behavioral sensitization (Wei 
et al., 2004). The GR transgenic mice do not have altered activity or reactivity 
to acute cocaine, but the increased susceptibility to sensitization of GR over-
expressing mice implies changes in hyperresponsivity to strong emotional stimuli. 
Therefore, GRs are well positioned as potential mediators of glucocorticoid-
mediated neuroplasticity in addiction, although the mechanisms are yet unclear. 
The medial PFC may play different roles in the regulation of the HPA axis. 
PFC consists of a dorsal part including the anterior cingulate cortex and a ventral 
part including prelimbic and infralimbic cortex. Both parts are implicated in 
executive functioning and enable flexibility in affective processing (Bush et al., 
2000). In rat, the prelimbic subdivision of PFC is involved in reward and stress 
response inhibition through projections that include NAc and basolateral amyg-
dala, whereas the infralimbic PFC influences visceral/autonomic activity and is 
implicated in stress excitation (Herman et al., 2005; Vertes, 2004). The develop-
ment of HPA responses to stress is altered by adverse events in early life. MS 
triggers a decrease in dendritic length, spine density (Monroy et al., 2010) and 
impairs long-term potentiation processes in the PFC (Baudin et al., 2012; 
Chocyk et al., 2013). The development of HPA responses during stress is 
affected also through alterations in gene transcription, including the GR. GR 
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functions to repress stress-induced responses, however it’s activation in the 
forebrain can also lead to delayed inhibition of HPA activity through negative 
feedback inhibition (Kloet et al., 2005). The network properties are altered in a 
way that experiences are remembered and stress responsiveness is preserved. 
GR knockdown in the prelimbic PFC increases basal morning corticosterone 
release suggesting its involvement in the basal tone of the HPA axis under 
chronic stress (McKlveen et al., 2013). Conversely, overexpression of GR in the 
forebrain leads to a emotionally labile phenotype (Kloet et al., 2005). GR in the 
infralimbic PFC may be involved in the sensitization to chronic stress that indi-
cates to a functional diversity of GR within the PFC (McKlveen et al., 2013).  
 
 
9.2. Epigenetic mechanisms in stress 
Studies on the mechanisms that shape stress reactivity and regulation have also 
pointed to DNA methylation. Translation studies in humans suggest an effect of 
parental care on the epigenetic regulation of hippocampal GR expression, where 
greater methylation of the exon 17 GR promoter was detected in the offspring of 
the low-licking/grooming mothers (McGowan et al., 2009; Weaver et al., 2004). 
Differences in the methylation status of GR developed between PND1 and 
PND6. Therefore, early environmental events may decrease hippocampal GR 
expression and increase HPA activity that has been associated with higher risk 
to psychopathology.  
However, mixed results have been found in other studies depending on the 
adverse experience and age of offspring. Reduced methylation of GR promoter 
was associated with childhood maltreatment and substance-use disorders in 
adults (Tyrka et al., 2016). Differential DNA methylation of HPA-related genes, 
such as CRH, GR and FKBP5 (FKBP prolyl isomerase 5), have been associated 
in a prenatal study with chronic and war-related stressors (Kertes et al., 2016). 
These epigenetic mechanisms may continue operating the stress regulation also 
postnatally.  
MS seems to induce changes in the overall status of DNA methylation in the 
genome. Our previous studies have shown that MS increased the expression of 
Dnmt1, Dnmt3a, Dnmt3b that persisted into adulthood (Anier et al., 2014) and 
the augmented expression levels of Dnmt resulted in alterations in the DNA 
methylation both at a global and local levels on neuronal plasticity-related genes 
(Anier et al., 2014). However, global changes in DNA methylation may remain 
unaffected. MS does not alter global methylation in the adult PFC (Anier et al., 
2014; McCoy et al., 2016). Early life stress affects local alterations also in GABA 
and glutamate signaling possibly accounting for the cognitive phenotype after 
stress. For example, the hippocampal and PFC expression of some glutamate 
receptor subunits decrease after MS indicating that early life stress reprograms 
inhibitory and excitatory signaling (Burns et al., 2018). BDNF (brain-derived 
neurotrophic factor) plays an important role in neurodevelopment, neurogenesis 
and synaptic connectivity throughout life and its signaling has been associated 
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with early life stress, although some epigenetic changes in BDNF are transcrip-
tionally silent (Burns et al., 2018). 
Local MS-induced alterations in DNA methylation have also been shown in 
the HPA axis-associated genes, including GR in adult mice (Kember et al., 
2012), although the role of GR remains unclear as other studies show no altera-
tion in the methylation of GR promoter (Daniels et al., 2009). The increased 
expression of a key regulator in the HPA axis, CRF, along with decreased DNA 
methylation at the Crf promoter in the PVN of mice in the coincides with social 
stress behavior and both effects are reversed by chronic antidepressant treatment 
(Elliott et al., 2010), thus antidepressant treatment can change DNA methylation 
levels and this affects both transcriptional and behavioral outcomes. Moreover, 
knockdown of Crf decreased stress-induced social avoidance, therefore taken 
together, direct epigenetic regulation of Crf could be a mechanism that regulates 
long-term behavioral response to stress (Elliott et al., 2010). 
Epigenetic modifications occurring in early life may be reversible with 
epigenetic modulators. Trichostatin A, a HDAC (histone deacetylase) inhibitor, 
reversed the hypermethylated status of GR exon 17 promoter in adult offspring 
of low licking/grooming mothers and re-established HPA responsiveness to stress 
(Cervoni and Szyf, 2001; Weaver et al., 2004). Conversely, methionine injections 
to the offspring of high licking/grooming mothers resulted in increased methyla-
tion of GR and higher HPA responsiveness to stress (Weaver et al., 2005). How-
ever, in humans, the GR 1F promoter hypermethylation in infants of depressed 
mothers was not reversed by antidepressant treatment (Bagot et al., 2014).  
Interestingly, it was recently proposed that patterns of neuronal activity by 
early life experience restricts the amount of DNMT3A-mediated non-CpG 
methylation on gene bodies (Stroud et al., 2017). DNMT3A expression traject-
ories may differ in the brains of primates and rodents, therefore DNMT3A-
dependent epigenetic gene expression may still have different strategies in 
rodents and humans, especially in postnatal brain development (Cardoso-Moreira 
et al., 2019; Pruunsild and Bading, 2019). In rodents, Dnmt3a expression levels 
increase transiently after birth, whereas in the human brain, its expression is 
retained in high levels in early embryonic stage and decrease to low levels 
postnatally (Cardoso-Moreira et al., 2019). Whether the DNMT3A2 isoform is 
activity-regulated in humans is yet unknown.   
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AIMS OF THE STUDY 
The general aim of the dissertation is to assess the involvement of DNA methyl-
ation in cocaine-induced changes of neuroplasticity in the predisposition, expres-
sion and abstinence of cocaine abuse. The specific aims of the thesis are as 
follows: 
 
1. In the predisposition phase, to study the molecular mechanism of GR-
mediated genomic regulation of DNA methyltransferases on a maternal 
separation model of early life stress. 
 
2. In the expression and abstinence phase, to describe the effect of acute and 
chronic cocaine on DNA methylation enzymes in an addiction-specific 
(NAc) and non-specific regions (cerebellum, peripheral blood cells). 
 
3. In the expression and abstinence phase, to characterize the role of DNMT3A 




MATERIALS AND METHODS 
1. Animals 
Wistar rats were obtained from Harlan Laboratories (Netherlands) and adult 
male C57BL/6NTac mice were purchased from Taconic Biosciences (Den-
mark). Animals were housed in standard polypropylene cages under 12-hour 
light-dark cycle with lights on at 7:00 a.m. Animals were allowed free access to 
food and water except during experimental procedures. All behavioral experi-
ments were performed during the light phase in an isolated room. 
 
 
2. Drug treatments 
Cocaine hydrochloride (8 mg/kg or 15 mg/kg; Sigma-Aldrich, St. Louis, MO, 
USA) or procaine hydrochloride (15 mg/kg or 45 mg/kg; Sigma-Aldrich, 
St. Louis, MO, USA) was injected to mice intraperitoneally (i.p.). Compounds 
were diluted in 0.9% NaCl (B. Braun Melsungen AG, Germany). Saline group 
animals received an equal volume of 0.9% NaCl i.p. RG108 (0.6 mg/mL, 
Sigma‐Aldrich, St. Louis, MO, USA) was dissolved in 0.9% NaCl containing 
10% dimethyl sulphoxide (DMSO, Sigma-Aldrich, St. Louis, USA). 
Corticosterone (1 mM, Sigma-Aldrich, St. Louis, USA) and mifepristone 
(0.4 mM, Sigma-Aldrich, St. Louis, USA) stock solutions were dissolved in 
DMSO and subsequently diluted in Neurobasal-A (Invitrogen, Carlsbad, USA). 
On 5th day in vitro (DIV5) corticosterone 1, 5, 10 and 50 µM (final concen-
tration in the medium) alone or in combination (50 μM corticosterone) with 
mifepristone 20 µM (final concentrations in the medium) was added to primary 
cells for 3 hours. Cells were washed with an ice-cold phosphate buffered saline 
(PBS) and immediately lysed for RNA isolation.  
 
 
Figure 1. Experimental timeline. Adult mice were injected (i.p.) a single dose of 
cocaine (15 mg/kg) or procaine (45 mg/kg). Control mice received saline injections. 
Tissues were isolated 0.5 h and 24 h after injections. 
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3. Locomotor activity and tissue isolation 
Horizontal locomotor activity was detected with a PhenoTyper (Noldus Infor-
mation Technology, Netherlands) during 60 min after the i.p. injections on the 
1st, 7th, 28th and 35th day. Each animal was tracked individually.  
The NAc, cerebellum (Cer) and peripheral blood cells (PBC) were isolated 
at 0.5 h and 24 h after acute cocaine injection and 0.5 h and 24 h after procaine 
treatment (Figure 1, experimental design), and in repeated cocaine experiments, 
tissues were isolated 2 h or 24 h after cocaine challenge dose (Figure 2, experi-
mental design). Trunk blood samples were collected in EDTA-containing tubes. 
Serial 1-mm thick sections were prepared using a brain matrix and NAc was 
dissected with a round-shape puncher (inner diameter 1.5 mm) on chilled 
microscope slides. Tissues were frozen immediately in liquid nitrogen and 
stored at –80 °C.  
 
Figure 2. Experimental timeline. Adult mice were injected (i.p.) cocaine (15 mg/kg per 
day) or saline for 7 consecutive days. On day 28, animals received cocaine (8 mg/kg) or 
saline injections. Tissues were isolated 0.5 h and 24 h after injections. Locomotor 
activity was measured for 60 min after last injection. 
 
 
4. Induction and expression of behavioral sensitization 
Induction of behavioral sensitization. Animals were randomly assigned to fol-
lowing groups: (1) saline (SS), mice received saline for 7 days; (2) acute 
cocaine (SC), mice received saline for 6 days and cocaine (15 mg/kg) on the 7th 
day; (3) repeated cocaine (CC), mice received cocaine (15 mg/kg) for 7 days. 
Expression of behavioral sensitization. Animals were assigned to one of the 
following groups: (1) saline + saline (SS), mice received saline for 7 days and 
were treated with saline on the 28th (experimental design 0) or the 35th 
(experimental design I) day; (2) saline + cocaine (SC), mice received saline for 
7 days and were treated with a challenge dose of cocaine (8 mg/kg) on the 
28th day; (3) cocaine + saline (CS), mice received cocaine (15 mg/kg) for 
7 days and saline on the 28th day; (4) cocaine + cocaine (CC), mice received 
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5. Maternal separation 
Maternal separation was performed as described previously (Anier et al., 2014). 
Briefly, male pups were randomly assigned to three experimental groups: animal 
facility reared (AFR), handled (MS15) and maternally-separated (MS180) group. 
MS15 pups were handled and individually separated for 15 min and then returned 
to the home cage. MS180 pups were individually placed into new cages for 
180 min per day from PND2 to PND14 and then returned to the home cage. The 
bedding (aspen chips) and nesting material (aspen wool) was changed on 
PND10 in all cages. The procedure for MS15 and MS180 groups began at 
10:00 a.m. and the dam and pup behavior was oberved in their home cage for 
10 min. AFR is considered as the control group and the comparison of MS15 
and MS180 groups shows the effect brought about by maternal separation. The 
researchers were not blinded to the experimental group during the experiments, 
decapitation and data analysis. Decaptitation was performed in a separate room 
in a randomized manner on PND15. Trunk blood samples were collected in 
EDTA-containing tubes between 10:00 and 11:00 a.m. Medial PFC, including 
the prelimbic region, was dissected by using a brain matrix according to rat 
brain atlas landmarks (Paxinos and Watson, 1986), frozen in liquid nitrogen and 
stored at –80 °C.  
 
 
6. Rat primary neuronal culture 
Rat primary cultures were prepared from male and female newborn (1st 
postnatal day) Wistar rats or from embryonic day 21 Sprague Dawley rats as 
described previously (Jaako et al., 2016; Koppel et al., 2015). Briefly, cortices 
were dissected in ice-cold Krebs-Ringer solution (135 mM NaCl, 5 mM KCl, 
1 mM MgSO4, 0.4 mM K2HPO2, 15 mM glucose, 20 mM HEPES, pH 7.4) 
containing 0.3% bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, USA). 
Tissue was trypsinized in 0.8% trypsin (Sigma-Aldrich, St. Louis, USA) for 
10 min at 37 °C and triturated in 0.008% DNase (Sigma-Aldrich, St. Louis, 
USA) solution containing 0.05% soybean trypsin inhibitor (Sigma-Aldrich, St. 
Louis, USA). Cells were resuspended in Basal Medium Eagle with Earle’s salts 
(Sigma-Aldrich, St. Louis, USA) containing 10% heat-inactivated fetal bovine 
serum (Life Technologies, Carlsbad, USA), 25 mM KCl, 2 mM GlutaMAXTM-I 
(Invitrogen, Carlsbad, USA), 100 µg/ml gentamicin (KRKA, Novo Mesto, 
Slovenia) and plated onto poly-L-lysine-coated (Sigma-Aldrich, St. Louis, 
USA) 35-mm dishes (Nunc, Thermo Fisher Scientific, MA, USA). The medium 
was changed to Neurobasal-A supplemented with B-27 (both from Invitrogen, 
Carlsbad, USA), 2 mM GlutaMAXTM-I, and 100 µg/ml gentamicin three hours 
later and cultured at 37 °C in a humidified 5% CO2 incubator. 
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7. Adeno-associated virus (AAV) vector generation and 
transduction in vitro 
The shRNAs were designed to target all known mouse and rat Dnmt3a 
transcripts equivalent to the target sequence of Silencer Select siRNA s65079 
(Thermo Scientific, Waltham, MA, USA). A scrambled shRNA sequence was 
used for specificity control that corresponded to Silencer Select negative control 
no. 2 siRNA (Thermo Scientific, Waltham, MA, USA). Oligonucleotides 
containing 21 base sense and antisense sequences linked with a hairpin loop 
(5′‐TTCAAGAGA‐3′) followed by a poly (dT) termination signal and comple-
mentary reverse oligonucleotides were purchased from Microsynth AG (Switzer-
land) and are listed in Table 1. 
 
Table 1. List of Dnmt3a-specific shRNA oligonucleotides sequences. 
Oligonucleotide name Sequence (5’ –> 3’) 





Scrambled shRNA sense GATCCCCACTACCGTTGTTATAGGTGTTCAAGAGACACCTATAACAACGGTAGTTTTTTGGAAA 
Scrambled antisense AGCTTTTCCAAAAAACTACCGTTGTTATAGGTGTCTCTTGAACACCTATAACAACGGTAGTGGG 
 
The corresponding complementary oligonucleotides were annealed and the 
double‐stranded DNA was ligated via BamHI and HindIII into an AAV expres-
sion vector (kind gift from H. Bading) under the U6 promoter. The AAV vector 
also contains mCherry under the Camk2a promoter. The shRNA encoding AAV 
vectors, serotype 1, were purchased from the University of Pennsylvania Vector 
Core (Philadelphia, PA, USA). 
On DIV2, cultured neurons were transduced with 7 × 1012 genome copies/mL, 
simultaneously with the replacement of one half of the medium. RNA and protein 
isolation was performed on DIV8. 
 
 
8. Intra-NAc AAV injections 
Mice were anesthetized with a mix of ketamine and xylazine. 3.5 × 1010 genome 
copies of AAV-Dnmt3a-shRNA (AAV-Dnmt3a) or AAV-Scrambled-shRNA 
(AAV-Scr) per hemisphere were injected bilaterally into mouse NAc (–1.3 mm 
anteroposterior, ±1.0 mm lateral, and –4.5 mm dorsoventral relative to bregma) 
using a Hamilton syringe (10 µl) connected to a motorized unit. Mice were 
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killed by decapitation 24 hours (experimental design I) and 2 hours (experimental 
design II) after cocaine challenge dose. Brains were cut on a brain matrix after 
the verification of injection coordinates and NAc was dissected using a round-
shape puncher (inner diameter 1.5 mm). Tissues were frozen immediately in 
liquid nitrogen and stored at –80 °C. Mice with incorrect injection sites were 




For TUJ1 (tubulin beta 3 class III, TUBB3) immunohistochemistry, free-floating 
coronal sections were incubated for 24 h at 4 °C with rabbit anti-TUJ1 mono-
clonal antibody (1:500, Covance, MRB‐435P, USA) that was followed by 
incubation with rabbit secondary antibody conjugated with Alexa-488 (1:1000, 
Thermo Fisher Scientific, USA) as described previously (Jaako et al., 2011). 
Nuclei were stained with 300 nM DAPI solution (4′,6-Diamidino-2-phenylindole 
dihydrochloride, Sigma-Aldrich, USA) in PBS. Representative images were 
captured with a confocal microscope (LSM 510 Duo, Zeiss, Germany) using a 




10. RNA isolation and quantitative PCR  
Total RNA was extracted from primary neuronal cells, rat PFC, mouse NAc and 
cerebellum using RNeasy Mini Kit (QIAGEN, Hilden, Germany) and mouse 
trunk blood using QIAamp RNA Blood Mini kit (Qiagen, Hilden, Germany). 
RNA was treated with DNase I (QIAGEN, Hilden, Germany) according to the 
manufacturer’s protocol. cDNA was synthesized from 750 ng rat RNA and 
200 ng mouse RNA using RevertAid First Strand cDNA Synthesis Kit with 
oligo(dT)18 primers (Thermo Fisher Scientific, Waltham, Massachusetts, USA). 
Quantitative PCR (qPCR) was performed using an ABI PRISM 7000 Sequence 
Detection System equipped with ABI Prism 7000 SDS Software (Applied 
Biosystems Inc, USA). Agarose gel electrophoresis and sequencing was used to 
confirm the specificity of PCR products. Results were calculted using the ΔΔCT 
method (Schmittgen and Livak, 2008) and were normalized to Gapdh 
(Glyceraldehyde-3-phosphate dehydrogenase). Rat primers for Dnmt1, Dnmt3a, 
Dnmt3b, Gapdh were designed to amplify all known transcripts of a given gene 
(Microsynth AG, Balgach, Switzerland). The primers used for amplifying 
specific rat Dnmt3a transcripts as well as primers for total mRNA are listed in 
Table 2 (Microsynth AG, Balgach, Switzerland). Mouse primers for Dnmt1, 
Dnmt3a, Dnmt3b, Gapdh, Esr1, Grin1, Ppp1cc and Gal were designed to target 
all known transcripts, were synthesized by TAG Copenhagen AS (Copenhagen, 
Denmark) are listed in Table 2. 
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Table 2. List of rat and mouse RT-qPCR primer sequences. 
Organism Gene name Sequence (5’ –>3’) 






















Mouse Dnmt1 Forward: CCCATGCATAGGTTCACTTCCTTC  
Reverse: TGGCTTCGTCGTAACTCTCTACCT 
Mouse Dnmt3a Forward: GCCGAATTGTGTCTTGGTGGATGACA  
Reverse: CCTGGTGGAATGCACTGCAGAAGGA 
Mouse Dnmt3b Forward: TTCAGTGACCAGTCCTCAGACACGAA 
Reverse: TCAGAAGGCTGGAGACCTCCCTCTT 
Mouse Gapdh Forward: GTCATATTTCTCGTGGTTCACACC 
Reverse: CTGAGTATGTCGTGGAGTCTACTGG 
Mouse Esr1 Forward: GAAGGCCGAAATGAAATGGGTG 
Reverse: GGTCAGCTGTCAAGGACAAG 
Mouse Grin1 Forward: ACTCCCAACGACCACTTCAC  
Reverse: GTAGACGCGCATCATCTCAA 
Mouse Ppp1cc Forward: CACGAGACCTGTCACACCAC  
Reverse: CAGTAATCAAATGGAGGAGGGC 




11. Chromatin immunoprecipitation assay  
PFC ChIP was performed as described previously (Pruunsild et al., 2011). 
Primary neuron ChIP experiments were performed from newborn Wistar rats 
using 5 × 106 cells per sample and according to ChIP kit instructions (ab500, 
Abcam, Cambridge, UK) with minor modifications. Primary neurons were 
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treated with CORT for 1 h, washed with 1× PBS, harvested by scraping and 
then cross-linked with 1% formaldehyde for 10 min at room temperature and 
the reaction was quenched by adding 0.12 M glycine. After obtaining a nuclear 
lysate (supplemented with protease inhibitors cOmplete Protease Inhibitor 
Cocktail from Roche, Basel, Switzerland), chromatin was then sonicated (Dia-
genode Bioruptor) with the following settings to obtain DNA fragments of an 
average length of 500 bp: high (H) power output, 30 sec ON/30 sec OFF pulses, 
total sonication time 8 min, 4 °C water bath with no floating ice. The cell debris 
was pelleted by centrifugation (17900 g for 15 min at 4 °C). For ChIP, the 
supernatant was diluted with 1x ChIP buffer and samples were rotated with 3 µg 
GR antibody (ab3579, Abcam, Cambridge, UK) or no antibody overnight at 
4 °C. On the following day, 50 µl of 50% protein A Sepharose CL-4B (GE 
Healthcare, Little Chalfont, UK) slurry was added to each sample and the mix 
was rotated for 1 h at 4 °C. After washes, the immune complexes were eluted 
from Sepharose three times using 50 µl elution buffer (1% SDS, 100 mM 
NaHCO3); eluates from the same samples were combined. Cross-linking was 
reversed by incubating eluates with 250 mM NaCl at 65 °C overnight. DNA was 
purified using QIAquick PCR Purification Kit (Qiagen, Hilden, Germany). 
Immunoprecipitated target genomic regions were quantified by qPCR using 
LightCycler 480 SYBR Green I Master qPCR mix (Roche, Basel, Switzerland) 
and the following primers (synthesized by Microsynth AG, Balgach, 
Switzerland): Mb: forward (5’-TAGTGTGCATCCAGCAGAGG-3’), reverse  
(5’-ACACTGTGGCCTTTTTGTCC-3’); Per1: forward (5’-GGGTTGGGGGAG 
GCGCCAA-3’), reverse (5’-GGCGGCCAGCGCACTAGG-3’); Dnmt3a intron 3: 
forward (5’-TAAGCCAGAGCTTTCAGGGC-3’), reverse (5’-CGGTACAAA 
TGCAGGCTGTC-3’); Dnmt3a intron 5: forward (5’-AGAGGATAGACACTGG 
GCCG-3’), reverse (5’-AGCTGAAGCTGGAAGAAGGC-3’); Dnmt3a pro-
moter: forward (5’-GACACGCTACACCTTCGAGT-3’), reverse (5’-CCCAGTC 
TCACCAACACCTC-3’); Dnmt3b promoter: forward (5’-AAAGCAGGAAGC 
AGTACGGG-3’), reverse (5’-CACACCGCATCAGCTTTTCG-3’) on a Light-
Cycler 480 II Real Time PCR System (Roche, Basel, Switzerland). ChIP was 
performed over 4 independent experiments for primary neurons and 5–7 animals 
per group were used for PFC ChIP. Data were presented as the percentage of 
starting material (% of input). Results were log-transformed for statistical 
analysis and back-transformed for graphical representation as a box blot. 
Whiskers represent max and min data points. MatInspector 8.4.1 (Cartharius et 
al., 2005) was used for promoter and intragenic analysis. 
 
 
12. Western immunoblotting 
For total protein isolation, prefrontal cortices were homogenized in ice-cold 
radioimmunoprecipitation assay (RIPA) buffer [50 mM Tris, pH 8.0, 150 mM 
NaCl, 1% NP-40, 0.5% Na-deoxycholate, 1 mM PMSF, protease inhibitor 
cocktail (Roche, Switzerland)] and 0.1% SDS was added subsequently for 
40 
complete lysis. Primary neurons were lysed in ice-cold RIPA buffer (including 
0.1% SDS). Lysates were sonicated briefly and cell debris was removed by 
centrifugation (16 000 g, 15 min, 4 °C). Total protein concentrations were 
determined using a Pierce BCA Protein Assay Kit (Thermo Scientific, Waltham, 
MA, USA). 30 µg of total protein in 1 × Laemmli sample buffer was separated 
in 7.5% SDS–polyacrylamide gel and transferred to PVDF membrane (pore size 
0.45 µm, Merck Millipore, Darmstadt, Germany). The membranes were 
blocked with 3% bovine serum albumin (BSA) in TBS containing 0.1% Tween-
20 (TBST) for 1 h at room temperature and incubated with primary antibodies, 
anti-DNMT3A (1:500, ab2850, Abcam, Cambridge, UK), anti-GAPDH (1:2500, 
MAB374, Merck Millipore, Darmstadt, Germany), diluted with 5% BSA in 
TBST. The following secondary antibodies were used, Stabilized Peroxidase 
Conjugated Goat anti-rabbit and anti-mouse (1:5000, both from Thermo 
Scientific, Waltham, MA, USA), diluted with 2% skim milk in TBST. Chemo 
luminescence signal was detected using SuperSignal West Femto Chemi-
luminescent Substrate (Thermo Scientific, Waltham, MA, USA) and ImageQuant 
LAS 4000 bioimager (GE Healthcare, Finland). ImageQuantTL software (GE 
Healthcare, Finland) was used to quantify signals from non-saturated exposures. 
DNMT3A levels were normalized to GAPDH and expressed as mean optical 
density (OD) ratio relative to control group ± SEM. Immunoblotting of PFC 
was performed in duplicates per animal and using 7 animals per group. 
 
 
13. DNMT activity measurements 
Nuclear proteins were isolated from mouse NAc, Cer and PBCs and rat PFC 
using Nuclear Extraction Kit (Abcam, Cambridge, UK). EpiQuik DNMT activity 
assay kit (Epigentek Group, Brooklyn, NY, USA) was used to detect DNMT 
activity. Each experiment was performed in duplicate with 5 µg of nuclear 
protein extracts for each assay. DNMT activity levels were measured at 450 nm 
using a Tecan Sunrise plate reader (Tecan Group Ltd., Switzerland) and 




14. Plasma corticosterone assay 
Rat blood samples were centrifuged at 4000 × g for 5 min for plasma extraction 
and stored at −80 °C. Plasma corticosterone concentrations were measured using 
corticosterone ELISA kit (Abcam, Cambridge, UK) according to the manufac-
turers’ instructions. OD was measured at 450 nm using Tecan Sunrise microplate 
reader (Tecan Group Ltd., Switzerland). Sensitivity for the corticosterone assay 
was 0.3 ng/ml, and all samples were analyzed in duplicate in a single assay; the 
intra-assay coefficient of variation was 6.2%. Total corticosterone concen-
trations are expressed as nanogram per ml plasma (ng/ml).  
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15. Global 5-mC quantification 
Genomic DNA was isolated from the NAc using a QIAamp DNA Micro kit 
(Qiagen, Hilden, Germany) and DNA was digested into individual nucleosides 
using DNA Degradase Plus (Zymo Research, Irvine, CA, USA) according to 
manufacturer's protocols. 10 µl of the DNA was used for liquid chromatography 
electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) to measure 
5-mC and 5-hmC levels.  
Chemicals. Methanol was purchased from J. T. Baker (Deventer, Nether-
lands) and ammonia was obtained from Riedel-de-Haën (Seelze, Germany). 
1,1,1,3,3,3-hexafluoroisopropanol (HFIP) was purchased from Sigma-Aldrich 
(St. Louis, MO, USA). DNA standards containing cytosine, 5-mC or 5-hmC were 
from Zymo Research (Irvine, CA, USA), and cytosine, 5-mC standards were 
from Sigma-Aldich (St. Louis, MO, USA). 
LC-ESI-MS/MS assay. Chromatographic separation of the analytes was per-
formed using an Agilent Series 1100 LC-MSD Trap XCT (Agilent Techno-
logies, Santa-Clara, CA, USA) equipped with a binary pump, a degasser, an 
auto-sampler and a column thermostat. Validation and quantification of cytosine, 
standard solutions of cytosine, 5-mC in water and digested cytosine, 5-mC and 
5-hmC standards were performed. Standards were diluted in water, DNA hydro-
lysis standards and digested samples (10 μL) were injected onto a reverse phase 
liquid chromatography column (Waters XBridge C18 column (150 mm × 3 mm, 
3.5 μm) equipped with a Waters Guard Cartridge (20 mm × 4.6 mm) (Waters, 
Milford, MA, USA) and were eluted at a flow rate of 0.3 mL/min. ESI-MS 
detection was performed in positive ion detection mode. Analytes were eluted 
using a two component eluent with 5 mM HFIP buffer at pH 9 (adjusted using 
ammonia) and methanol with the following gradient program: eluation started at 
4% methanol, followed by increase to 12% methanol in 5 minutes and further 
increase to 100% methanol within the next 5 minutes. Methanol content was 
maintained at 100% for 3 minutes and was then reduced to 4% in the course of 
2 minutes. For column equilibration, a 5-minute post-run was used. The column 
temperature was 30 °C. MS detection of the analytes was performed in the 
multiple reaction monitoring (MRM) mode using previously optimized conditions 
(5 mC m/z 242→126, 5-hmC m/z 258→142 and deoxycytidine (Cyt) m/z 
228→112). Quantifications of 5-mC and 5-hmC were performed as previously 
described (Kaas et al., 2013). 
 
 
16. 5-mC quantification at Esr1 and Grin1 
Genomic DNA (gDNA) from mouse NAc and PBC was isolated using DNeasy 
Blood and Tissue Kits (Qiagen, Hilden, Germany) according to manufacturer’s 
protocol. For PBC, the DNA of 2 mice was pooled and three pools were used 
for the assay. For the NAc, no pools were used; thus, each array corresponded 
to 1 single mouse. In total, 6 mice were used per group for the NAc. The 5-hmC 
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and 5-mC levels at Esr1 were detected using the EpiMark 5-hmC and 5-mC 
Analysis Kit (New England Biolabs, MA, US). Briefly, 2.3 mg of NAc and 7 
mg of blood gDNA were treated with T4 Phage b-glucosyltransferase according 
to the manufacturer’s instructions. Glucosylated gDNA was digested using 100 
U of MspI, 50 U of HpaII or no enzyme (negative control for digestion) at 
37 °C for 16 h. Digestion was terminated using Proteinase K at 40 C for 30 min 
and the reaction was inactivated at 95 C for 10 min. The qPCR primers for 
specific 5-mC detection are the following: Esr1: forward, (5’-GAAGCTAGCG 
GTTCCTTGGG-3’), reverse, (5’-TGCGATTAGAGAAGGCGCAG-3’), Grin1: 
forward, (5’-CCGCTC AACCTCTCAGATCC-3’), reverse, (5’- CTCATCAG 
TGTCCTTGGCCG-3’). Quantification of the methylation status of the inner C 
at the specific CCGG site was calculated by subtraction of the Ct values 
according to the manufacturer's instructions. 
 
 
17. Statistical analysis 
The sample size was predetermined during preliminary and previously published 
experiments (Anier et al., 2014, 2013) and statistical significance levels were 
set to p < 0.05. Definition for unit of analysis (n) for all experiments is provided 
in the results and in the figure legends. Data points outside of 99% confidence 
intervals were considered outliers and excluded from further data analysis 
unless stated otherwise at figure legend. Exact numbers for all experiments are 
provided in the results and in the figure legends. For statistical analysis, all data 
were log-transformed to obtain normal distribution of the data. RT-qPCR, 
Western blot, ELISA, DNMT activity and global 5-mC data were analyzed 
using Student’s t-test (in the case with data in two groups) or one-way ANOVA, 
followed by Bonferroni post-hoc test. For graphical representation data were 
back-transformed into linear scale and presented as mean ± SEM. Student’s t-
tests followed by False Discovery Rate correction (Q was set to 5%) was 
performed on in vitro and in vivo ChIP-RT-qPCR data and for graphical re-
presentation data were back-transformed into linear scale and presented as a box 
plot, whiskers showing max to min data points. Locomotor activity data were 
analyzed using one-way or two-way ANOVA, followed by Bonferrori post-hoc 
test. Only hypotheses specified a priori were tested for statistical significance. 





All experiments were performed in accordance with EU guidelines (Directive 
2010/63/EU) and with experimental protocols approved by the Animal Welfare 
Committee of the Ministry of Rural Affairs, Republic of Estonia.  
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RESULTS 
1. Glucocorticoid receptor stimulation resulting  
from early life stress affects the expression of DNMT  
in rat prefrontal cortex (Paper I) 
1.1. Maternal separation increases corticosterone levels at PND15 
Stress is a well known risk factor for drug abuse disorder and PFC is one of the 
principal targets of glucocorticoids (McEwen, 2007). GR regulation is involved 
in stress-induced dopaminergic signaling in the PFC and in the glutamatergic 
neurotransmission from the PFC to the NAc (Butts et al., 2011; Campioni et al., 
2009), but the GR-dependant mechanism remains unclear. We have previously 
shown an early life stress-induced increase in Dnmt1, Dnmt3a and Dnmt3b 
expression in the NAc (Anier et al., 2014) and thus we hypothesized that GR as a 
transcription factor mediates the stress response by genomic regulation of Dnmt.  
We used the rat MS model of early life stress to study the role of GR 
stimulation on Dnmt expression (Fig. 3A). We assessed the plasma CORT levels 
at PND15 that indicates the development of HPA axis hyperactivity in response 
to stress. Increase in CORT was evident in the handling control group (MS15) 
and in the MS group separated from the dam and littermates for 180 min 
per day 24 hours after the last separation event (Fig. 3B, F(2, 15) = 322.2, 
****p < 0.0001, AFR vs. MS15; ****p < 0.0001, AFR vs. MS180). CORT 
levels were markedly increased in the MS180 pups in comparison with MS15 
group indicating higher HPA axis activity after MS (Fig. 3B, ####p < 0.0001, 
MS15 vs. MS180).  
 
 
Figure 3. Maternal separation increases plasma corticosterone levels. (A) Experimental 
timeline. Male pups were separated to individual cages on PND2-14 for 15 min or 180 
min/daily. (B) Plasma corticosterone was increased 24 h after last separation event both 
in MS15 and MS180 pups (Bonferroni post-hoc test after one-way ANOVA, 
****p < 0.0001, in comparison with AFR, ####p < 0.0001, MS15 vs MS180); error 
bars indicate SEM; n = 6. 
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1.2. Maternal separation is associated with increased Dnmt1,  
Dnmt3a, Dnmt3b expression and DNMT activity 
We studied Dnmt expression after MS in the PFC of male rats at PND15. 
Dnmt3a, Dnmt3b mRNA was increased in the PFC of both MS15 and MS180 
groups, while Dnmt1 mRNA increased in MS180 animals (Fig. 4A–C; Dnmt1,  
F(2, 16) = 66.19, ****p < 0.0001, AFR vs. MS180; Dnmt3a, F(2, 16) = 90.00,  
****p < 0.0001, AFR vs. MS180; Dnmt3b, F(2, 16) = 121.5, **p < 0.01, AFR vs. 
MS15, ****p < 0.0001, AFR vs. MS180). There was a notable increase in the 
expression of Dnmt1, Dnmt3a, Dnmt3b in the PFC after MS (Fig. 4A–C; MS15 
vs. MS180, Dnmt1, ####p < 0.0001; Dnmt3a, ####p < 0.0001, Dnmt3b,  
####p < 0.0001).  
 
 
Figure 4. Maternal separation increases total mRNA of (A) Dnmt1, (B) Dnmt3a,  
(C) Dnmt3b in the PFC. Bonferroni post-hoc test after one-way ANOVA, **p < 0.01,  
****p < 0.0001, in comparison with AFR, ####p < 0.0001, MS15 vs MS180); error 
bars indicate SEM; n = 6 – 7. 
 
To date, rat Dnmt1 and Dnmt3b have been described with a single transcript 
each. Two transcripts are known of rat Dnmt3a gene (Fig. 5A). Dnmt3a 
transcripts were measured in another cohort of MS littermates that had an 
increase in total mRNA (Fig. 5B, F(2, 13) = 11.72, **p = 0.002, AFR vs. MS15, 
**p = 0.0073, AFR vs. MS180). Dnmt3a1 mRNA was induced in the handling 
(MS15) group (Fig. 5C, F(2, 12) = 4.022, *p = 0.0457, AFR vs. MS15). 
Interestingly, transcript 2 was greatly increased in MS180, but not in MS15 rats 
and also augmented by MS stress alone (Fig. 5D, F(2, 12) = 5.745, *p = 0.0329, 
AFR vs. MS180, #p = 0.043, MS15 vs. MS180). Dnmt3a has a considerable 
contribution to DNA methylation in postmitotic cells, as the expression of 
Dnmt1 and Dnmt3b is greatly decreased in postnatal neural cells (Yue et al., 
2014). At the protein level, DNMT3A1 expression was increased in the MS180 
group (Fig. 5E–F, F(2, 18) = 5.798, p = 0.0095, AFR vs. MS180). 
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Figure 5. Dnmt3a expression changes after MS procedure. (A) Genomic structure 
(chr6:28235695-28,340,577) of Dnmt3a with introns drawn in scale displaying the two 
encoded transcripts. Total mRNA of (B) Dnmt3a, (C) Dnmt3a transcript 1 and 
(D) Dnmt3a transcript 2 after MS for 15 min or 180 min. (E – F) Representative 
Western blot bands of DNMT3A1 expression and quantitative data analysis normalized 
to GAPDH. Results are presented as mean OD ratio relative to control group. (B–D)  
n = 5–7; (F) n = 9;  
 
Next, we detected DNMT activity using a DNMT enzyme activity assay that 
showed an increase in the PFC of MS180 rats that was induced by MS (Fig. 6, 
F(2, 18) = 10.90, ***p = 0.0006, AFR vs. MS180, #p = 0.0358, MS15 vs. MS180). 
Taken together, our data shows that maternal separation induces Dnmt3a 





Figure 6. DNMT activity increases after MS, 
presented as OD/h/mg of protein. Bonferroni post-
hoc test after one-way ANOVA, *p < 0.05,  
**p < 0.01, ****p < 0.0001, in comparison with 
AFR, #p < 0.05, MS15 vs MS180); error bars 
indicate SEM; n = 7. 
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1.3. In silico identified GR-binding elements  
in Dnmt3a and Dnmt3b are biologically relevant 
To determine the biologically relevant GR binding sites of Dnmt1, Dnmt3a, 
Dnmt3b, we studied the effects of GR stimulation in primary cortical neurons. 
Our preliminary observations in primary neurons indicated that stress-induced 
increase in Dnmt1, Dnmt3a, Dnmt3b mRNA may be mediated by GR. To 
determine an optimal CORT concentration for studying Dnmt expression in 
primary cells, we treated cortical neurons with increasing concentrations of 
CORT (1, 5, 10, 50 µM). Dnmt1, Dnmt3a, Dnmt3b expression were all upregu-
lated with 50 μM CORT (Fig. 7A–C, Dnmt1, *p = 0.0156; Dnmt3a, §p < 0.0001; 
Dnmt3b, §p < 0.0001, Vehicle vs. CORT). As 1 µM CORT treatment only had 
an effect on Dnmt3b mRNA and no changes were seen with 5 µM CORT (Fig. 
7C; Dnmt3b, *p = 0.0218, Vehicle vs. 1 μM CORT), 50 μM CORT was chosen 
for molecular studies that indicated GR-mediated regulation for CORT-induced 
expression of Dnmt1, Dnmt3a and Dnmt3b (Fig. 7D–F, Dnmt1, F(2, 3) = 55.29, 
##p = 0.0043; Dnmt3a, F(2, 3) = 31.44, #p = 0.0137; Dnmt3b, F(2, 3) =12.02, 




Figure 7. GR mediates CORT-induced increase in Dnmt1, Dnmt3a, Dnmt3b 
expression. CORT was added in increasing concentrations to primary cortical neurons 
and 50 μM CORT upregulated Dnmt1, Dnmt3a and Dnmt3b mRNA (A–C). GR 
antagonist mifepristone abolished the CORT-induced increase in Dnmt1 (D), Dnmt3a 
(E), Dnmt3b (F) expression. Bonferroni post-hoc test after one-way ANOVA, *p < 0.05,  
§p < 0.05, in comparison with vehicle, #p < 0.05, in comparison with CORT; error bars 
indicate SEM; (A–C) n = 4, (D–F) n = 2. 
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Figure 8. Genomic structure of rat Dnmt3a and Dnmt3b (chr3:149,131,541–149,170,061) 
with introns drawn in scale showing the in silico found locations of glucocorticoid 
(GRE), progesterone (PRE), mineralocorticoid (MRE) and androgen response elements 
(ARE).  
 
Based on transcription factor binding site analysis, four loci were selected for 
study that included putative genomic GR-binding regions: Dnmt3a and Dnmt3b 
promoters, Dnmt3a intron 3 and intron 5 (Fig. 8A). GR immunoprecipitated 
from all selected regions except Dnmt3a intron 5 in comparison with the 
negative control region (Fig. 9A, **p = 0.004, Dnmt3b promoter Vehicle vs. 
Negative control Vehicle; **p = 0.007, Dnmt3b promoter 1 h CORT vs. 
Negative control 1 h CORT, ***p = 0.0002; Dnmt3a promoter Vehicle vs. 
Negative control Vehicle; ***p = 0.0005, Dnmt3a promoter 1 h CORT vs. 
Negative control 1 h CORT; **p = 0.005, Dnmt3a intron 3 Vehicle vs. Negative 
control Vehicle; *p = 0.06, Dnmt3a intron 3 1 h CORT vs. Negative control 1 h 
CORT). GR binding remained unaltered in all selected loci after CORT 
treatment (in comparison with vehicle). These results confirm the biological 
relevance of the in silico predicted GR binding sites at Dnmt3a and Dnmt3b. 
 
Figure 9. GR binds to Dnmt3a and Dnmt3b promoters. ChIP-qPCR analysis of 
immunoprecipitated DNA with GR antibodies of (A) primary cortical neurons and (B) 
PFC. Data are presented as percent of total DNA. Per1 promoter was used as positive 
and Mb intron as a negative control region. False discovery rate correction after 
Student’s t-tests, *p < 0.05, **p < 0.01, ****p < 0.0001, in comparison with respective 
group’s binding to Neg control; ##p < 0.01, in comparison with AFR or MS15 group; 
error bars indicate SEM; (A) n = 4; (B) n = 5–7. 
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1.4. Glucocorticoid receptor binding increases at Dnmt3b  
in the PFC after maternal separation 
We assessed GR recruitment at Dnmt3a and Dnmt3b in the PFC after maternal 
separation. Interestingly, GR binding was detected by chromatin immuno-
precipitation at the Dnmt3b promoter in the PFC of MS180 rats, but not in the 
control groups (Fig. 9B, *p = 0.018, Dnmt3b promoter MS180 vs. Negative 
control MS180). GR binding at the Dnmt3b promoter increased after maternal 
separation (##p = 0.0096, MS15 vs. MS180). We also measured GR binding at 
the Dnmt3a promoter as well as Dnmt3a intron 3 independently of the presence 
of stress (Dnmt3a promoter, *p = 0.016, Dnmt3a promoter AFR vs. Negative 
control AFR; *p = 0.024, Dnmt3a promoter MS15 vs. Negative control MS15; 
**p = 0.007, Dnmt3a promoter MS180 vs. Negative control MS180;  
Dnmt3a intron 3, *p = 0.047, Dnmt3a intron 3 AFR vs. Negative control AFR; 
*p = 0.036, Dnmt3a intron 3 MS15 vs. Negative control MS15). In addition, we 
detected no change in GR mRNA after maternal separation (Fig. 10, F (2, 12) = 
0.4318), therefore the increased binding of GR at Dnmt3b promoter was not due 
to transcriptional activation of GR. Our results show that GR can directly 
regulate Dnmt3a and Dnmt3b expression in the PFC and suggests that the 









Figure 10. GR mRNA does not change after 
MS. Bonferroni post-hoc test after one-way 




2. Cocaine-induced epigenetic DNA modification  
in mouse addiction-specific and non-specific tissues  
(Paper II) 
2.1. The effect of acute drug treatments on Dnmt expression and 
enzyme activity in the brain and peripheral blood cells (PBC) 
The alterations in Dnmt1 and Dnmt3a expression in the NAc after cocaine 
injection has been described previously on the behavioral sensitization and self-
administration models (Anier et al., 2010; LaPlant et al., 2010). Firstly, we 
studied whether cocaine-induced changes in the expression of epigenetic 
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modifiers in the NAc can be detected in peripheral blood. Secondly, since 
cocaine as well as procaine inhibit voltage-gated sodium channels, we hypo-
thesized that cocaine may affect DNA methylation enzymes by blocking voltage-
sensitive sodium channels in the NAc and in PBC. The effects of cocaine and 
procaine treatments were assessed in adult mice. 
During the first half an hour of a single cocaine dose treatment Dnmt1, 
Dnmt3a expression decreased in the NAc (Fig. 11A, Dnmt1, F(3,20) = 4.438, 
*p = 0.0151; Dnmt3a, F(3,20) = 6.244, **p = 0.0036) and interestingly, the 
decrease is also reflected in peripheral blood cells (Fig. 11B, Dnmt1, 
F(3,20) = 3.792, *p = 0.0265; Dnmt3a, F(3,20) = 3.999, *p = 0.0221). No changes 
were seen in a reference brain region outside of the mesolimbic dopaminergic 
system, cerebellum (Cer) that is not directly related to cocaine-induced behavioral 
sensitization (Fig. 11C). However, 24 hours after the single cocaine injection, 
Dnmt1, Dnmt3a expression increased in the NAc (Fig. 11A, Dnmt1, t(12) = 5.893, 
***p < 0.0001; Dnmt3a, t(12) = 6.988, ***p < 0.0001) and an upregulation in 





Figure 11. Dnmt1, Dnmt3a, Dnmt3b 
mRNA is altered after acute cocaine 
injections in mouse (A) NAc, (B) 
peripheral blood cells, (C) cerebellum. 
Bonferroni post-hoc test after one-way 
ANOVA, *p < 0.05, **p < 0.01, ***p 
< 0.001, in comparison with SAL; error 




Moreover, DNMT activity levels increased in the NAc and PBC (Fig. 12A–B, 
NAc, t(10) = 4.347, **p = 0.0015; PBC, t(10) = 2.494, *p = 0.0317) and positive 
correlation was found between the DNMT activity increase in the NAc and 
PBC (Fig. 12C, r = 0.632, *p = 0.0274). In the NAc, Dnmt1, Dnmt3a had a bi-
phasical change in expression and remained increased 24 h after acute cocaine 
injection that is reflected also in PBC. The elevated DNMT enzyme activity in 
the NAc after acute cocaine correlates with its increase in PBC. 
 
 
Figure 12. DNMT activity increases 24 h after acute cocaine injections both in the 
(A) NAc and in (B) PBC. (C) Pearson’s correlation of DNMT activity levels in the NAc 
and in PBC. Student’s t-test, *p < 0.05, **p < 0.01, in comparison with SAL; error bars 
indicate SEM; (A–C) n = 7. 
 
Cocaine may affect DNA methyltransferases by inhibiting voltage-gated sodium 
channels, thus we used another ester-type local anesthetic to study the observed 
effects. A single dose of procaine (45 mg/kg) affected Dnmt3a expression in an 
analogous, biphasical manner in the PBC, but increasing Dnmt3a mRNA 0.5 h 
(Fig. 13A, t12 = 2.910, *p = 0.0131) and decreasing it 24 h after injection 
(Fig. 13B, t12 = 2.791, *p = 0.0163). Procaine treatment did not change Dnmt 
expression in the NAc (Fig. 13B). These results indicate that a single dose of 
procaine affects the dynamics of Dnmt3a expression in similar biphasic manner 
as cocaine, but in an opposite direction.  
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Figure 13. Acute procaine administration alters Dnmt3a mRNA in mouse PBC 
(A) 0.5 h and (B) 24 h after i.p. injections. Procaine administration did not change Dnmt 
expression in the NAc (C) 0.5 h and (D) 24 h later. Student’s t-test, *p < 0.05, in 
comparison with SAL; error bars indicate SEM; (A–D) n = 6–7. 
 
 
2.2. Repeated cocaine administration increases locomotor  
activity in mice 
Our next aim was to study the effect of withdrawal from repeated cocaine on 
DNA methyltransferases in the brain and PBC. An increase in Dnmt3a mRNA 
in the NAc after withdrawal from chronic cocaine has been previously shown 
on the behavioral sensitization and self-administration models (LaPlant et al., 
2010). We hypothesized that the acute cocaine-induced changes in Dnmt 
expression and activity observed both in the NAc and PBC persist after chronic 
cocaine in the behavioral sensitization model. 
Cocaine treatment for 7 consecutive days (AC) increased locomotor activity 
in mice indicating the development of behavioral sensitization (Fig. 14A,  
F(1,37) = 87.19, p < 0.0001; time F(1,37) = 8.36, p = 0.0064; interaction  
F(1,37) = 16.46, p = 0.0002; ***p < 0.001 cocaine 1st vs. 7th day). Mice that 
received a challenge dose of cocaine (RC) after three weeks of withdrawal from 
cocaine displayed an enhanced locomotion response implying behavioral 
sensitization (Fig. 14B, F (3,41) = 27.61, p < 0.0001; ***p < 0.001 SAL vs. RC). 
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The increased locomotor activity of RC mice in comparison with AC mice 
indicates the persistence of behavioral sensitization (#p < 0.001 AC vs. RC). 
A group of mice previously receiving repeated cocaine treatment and injected 
with saline (RS) three weeks later showed increased locomotor activity 
(*p < 0.05 SAL vs. RS) that implicates the presence of psychomotor response 
and the extent of placebo with saline challenge dose. 
 
 
Figure 14. Behavioral sensitization develops and persists in mice with chronic cocaine 
administration. Repeated cocaine injections increase locomotion response on (A) day 7 
in comparison with day 1. Bonferroni post hoc test after two-way ANOVA, 
***p < 0.001 cocaine group 1st vs 7th day, n = 8–16. A challenge dose of cocaine after 
withdrawal (RC) enhances locomotor activity (B) on day 28 in comparison with acute 
cocaine administration (AC). Bonferroni post hoc test after one-way ANOVA, 
*p < 0.05, ***p < 0.001 in comparison with SAL; #p < 0.001, AC vs RC and RS vs RC; 
error bars indicate SEM, n = 8–12.  
 
 
2.3. The effect of repeated cocaine treatment and  
withdrawal on Dnmt expression in the brain and PBC 
We measured Dnmt expression levels 24 h after the repeated cocaine injections 
in order to see the long-term effect after cocaine has been metabolized (half life 
about 1 h). We describe an increased expression of Dnmt1, Dnmt3a, Dnmt3b in 
the NAc after cocaine withdrawal that persists up to 24 h (Fig. 15, main effect 
of group: Dnmt1, F (3, 43) = 35.94, p < 0.0001; Dnmt3a, F(3,43) = 61.44, 
p < 0.0001; Dnmt3b, F(3,43) = 13.27, p < 0.0001; ***p < 0.001, **p < 0.01, 





Figure 15. Withdrawal after 
repeated cocaine and a challenge 
dose increases Dnmt mRNA in the 
NAc 24 h after last dose. Bon-
ferroni post hoc test after one-way 
ANOVA, *p < 0.05, **p > 0.01, 
***p < 0.001 in comparison with 
SAL; #p < 0.001, AC vs RC and 
RS vs RC; error bars indicate 
SEM, n = 6–14.  
 
 
In PBC, Dnmt1, Dnmt3a and Dnmt3b mRNA were also increased 24 h after the 
cocaine challenge (Fig. 16A, main effect of group: Dnmt1, F(3,39) = 8.187,  
p = 0.0002; Dnmt3a, F(3,39) = 11.25, p < 0.0001; ***p < 0.001, **p < 0.01,  
*p < 0.05 compared with SAL; #p < 0.05 RS vs. RC). The long-term increase in 
Dnmt1 and Dnmt3a expression in PBC seems to be independent of withdrawal 
and sensitization as observed in the NAc.  
Interestingly, Dnmt1, Dnmt3a and Dnmt3b expression was also increased in 
the Cer at 24 h (Fig. 16B, Dnmt1, F(3,37) = 11.17, p < 0.0001; Dnmt3a, 
F(3,37) = 12.13, p < 0.0001; Dnmt3b, F(3,20) = 8.572, p = 0.0002; ***p < 0.001, 
**p < 0.01 compared with SAL). Dnmt1 and Dnmt3a mRNA were upregulated 
independently of withdrawal and sensitization as in NAc, but the increase in 
Dnmt3b expression may be associated with withdrawal in the Cer.  
 
 
Figure 16. Dnmt1, Dnmt3a and Dnmt3b mRNA increases in (A) PBC and (B) Cer 24 h 
after a 3-week withdrawal period and a cocaine challenge. Bonferroni post hoc test after 
one-way ANOVA, **p > 0.01, ***p < 0.001 in comparison with SAL; #p < 0.001, RS 
vs RC; error bars indicate SEM, n = 6–14.  
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2.4. Repeated cocaine treatment and  
withdrawal affects DNMT enzyme activity in NAc and PBC 
As we found cocaine-induced changes in Dnmt expression, we asked whether 
repeated cocaine treatment also affects the enzyme activitiy of DNMT. DNMT 
activity was increased in RC group in the NAc 24 h after the cocaine challenge 
dose (Fig. 17A, main effect of group: F (3,23) = 19.43, p < 0.0001; ***p < 0.001 
compared with SAL; #p < 0.001 AC vs. RC and RS vs. RC). We found a 
notable increase in DNMT activity levels in the PBC of AC and RC mice, while 
the augmented activity level was higher in the NAc than in PBC (Fig. 17B, 
main effect of group: F(3,20) = 6.741, p = 0.0025; **p < 0.01, *p < 0.05 compared 
with SAL; #p < 0.05 RS vs. RC).  
 
 
Figure 17. Cocaine challenge enhances DNMT activity 24 h later in the (A) NAc and in 
(B) PBC. Bonferroni post hoc test after one-way ANOVA, *p > 0.05, **p > 0.01,  
***p < 0.001 in comparison with SAL; #p < 0.001, AC vs RC and RS vs RC; error bars 
indicate SEM, n = 7. 
 
Our data showed a strong positive correlation between Dnmt3a mRNA and 
DNMT activity in the NAc (Fig. 18A, r = 0.7758, ***p < 0.0001). Dnmt1 
mRNA increase contributes partially (49% in the NAc and 47% in PBC) to 
augmented DNMT activity in the NAc and PBC (Fig 18B–C, NAc, r = 0.6993, 
***p < 0.0001; PBC, r = 0.6883, ***p = 0.0002). 
 
 
Figure 18. Correlations between (A) Dnmt3a mRNA and DNMT activity in the NAc 
and (B–C) Dnmt1 mRNA and DNMT activity in (B) NAc and (C) PBC were analyzed 
24 h after cocaine challenge. 
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2.5. Cocaine withdrawal affects global levels of 5-mC 
Since cocaine withdrawal affected DNMT activity in the NAc, we quantified 
the global levels of 5-mC after cocaine withdrawal. Interestingly, we observed 
an increase in both 5-mC level after cocaine withdrawal and a challenge dose 
(Fig. 19, 5-mC, main effect of group: F (2, 12) = 9.329, p = 0.0036; *p < 0.05 
compared with SAL; #p < 0.01 AC vs. RC). These results show that withdrawal 






Figure 19. Global levels of 5-methylcytosine 
(5-mC) in the NAc were increased with 
withdrawal after repeated cocaine and a 
challenge dose (RC). Bonferroni post hoc 
test after one-way ANOVA, *p > 0.05, in 
comparison with SAL; #p < 0.001, AC vs 




2.6. The regulation of the expression of cocaine-induced genes after 
cocaine withdrawal 
We studied the DNA methylation status and the expression of several genes 
previously associated with repeated cocaine, namely estrogen receptor-1 (Esr1) 
and glutamate receptor subunit zeta-1 (Grin1) (Massart et al., 2015). The 
expression of Esr1 decreased and Grin1 mRNA increased in AC and RC mice 
in the NAc (Fig. 20A–B, Esr1, main effect of group: F(3,19) = 5.193, p = 0.0087;  
*p < 0.05 compared with SAL; Grin1, main effect of group: F(3,19) = 7.385,  
p = 0.0018, **p < 0.01, compared with SAL). Our results show that the expres-
sion levels of Esr1, Gal and Grin1 were also markedly affected in the PBC after 
cocaine withdrawal (Fig. 20C–D, Esr1, main effect of group: F (3, 19) = 4.446, 
p = 0.0158; *p < 0.05 compared with SAL; Grin1, main effect of group:  
F (3, 19) = 3.575, p = 0.0333, *p < 0.05, compared with SAL).  
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Figure 20. Cocaine challenge after prolonged withdrawal decreased Esr1 mRNA in the 
(A) NAc and (C) PBC and increased Grin1 mRNA in the (B) NAc and (D) PBC. 
Bonferroni post hoc test after one-way ANOVA, *p > 0.05, **p > 0.01, in comparison 
with SAL; error bars indicate SEM, n = 5–7.  
 
We performed a site specific detection of the methylation of a GC dinucleotide 
in Esr1 promoter. We used a glycosylation-mediated restriction enzyme approach 
and quantified the result with qPCR. DNA methylation analysis in the NAc 
revealed that withdrawal from repeated cocaine increases site-specific methyla-
tion in Esr1 promoter (Fig. 21A, main effect of group: F (3, 11) = 68.31, p < 0.0001; 
***p < 0.001 compared with SAL), a decrease in 5-mC was detected in the AC 
mice. No changes were seen in the promoter methylation in PBC (Fig. 21B). 
Thus, withdrawal from repeated cocaine is associated with an increase in a 
specific GC dinucleotide methylation in the Esr1 promoter in the NAc and a 
decrease in its expression that is also reflected in PBC. 
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Figure 21. Specific CG dinucleotide methylation in the Esr1 promoter increased in the 
(A) NAc, but not in (B) PBC with withdrawal from repeated cocaine. Bonferroni post 
hoc test after one-way ANOVA, ***p > 0.001, in comparison with SAL; ####p > 0.001, 
AC vs RS and AC vs RC; error bars indicate SEM, n = 3–6.  
 
We also confirm an increase in the methylation in a 3’ untranslated region 
(UTR) of Grin1 in the NAc after repeated cocaine injections that indicates a 
positive regulation between the site-specific DNA methylation and Grin1 
expression (Fig. 22A, ****p < 0.0001 compared with SAL). In the PBC, we 
detected a decrease in methylation at the 3’ UTR of Grin1 that indicates a 
negative regulation between DNA methylation and Grin1 expression in a tissue 
outside of the mesolimbic dopaminergic system (Fig. 22B, *p < 0.05, 
**p < 0.01, ****p < 0.0001 compared with SAL). Therefore, withdrawal from 
repeated cocaine is associated with an increase in the GC dinucleotides in the 
gene body and an increase in Grin1 expression in the NAc, but the methylation 




Figure 22. Methylation in Grin1 gene body is altered in the (A) NAc and (B) PBC after 
cocaine administration. Bonferroni post hoc test after one-way ANOVA, ***p > 0.001, 
****p < 0.0001, in comparison with SAL; ##p < 0.01, ###p < 0.001, ####p < 0.0001, 
AC vs RS, AC vs RC, RS vs RC, error bars indicate SEM, n = 3–6.  
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3. The role of DNA methyltransferase activity in cocaine 
treatment and withdrawal in the NAc of mice (Paper III) 
3.1. AAV-mediated Dnmt3a silencing is selective 
Previous studies suggest that DNMT inhibition affects cocaine seeking 
behavior, also in the abstinence phase of cocaine abuse (LaPlant et al., 2010; 
Massart et al., 2015). Thus, we hypothesized that DNMT activity has a crucial 
role in the cocaine-induced sensitization during withdrawal. Among the DNMT 
enzymes, Dnmt3a has an important role in the neuroadaptations during cocaine 
treatment (Anier et al., 2010; LaPlant et al., 2010). Thus, we also studied the 
role of DNMT3A in cocaine-induced sensitization for which we designed a 
shRNA to silence Dnmt3a mRNA in the mouse NAc. 
AAV encoded shRNA had a 100% similarity between the selected target 
sequence of Dnmt3a shRNA in mouse and rat to silence Dnmt3a. The 
specificity of the AAV-Dnmt3a-specific shRNA (AAV-Dnmt3a) was verified 
in rat primary neuronal culture, where Dnmt3a mRNA and protein levels were 
reduced 90% in comparison with a scrambled shRNA (AAV-scrambled) and 
Dnmt3b, Dnmt1 expression was not affected (Figure 23A–B, F(1,14) = 225.8, 
**p = 0.0025; t(2) = 16.29, **p = 0.003).  
 
 
Figure 23. Specific silencing of Dnmt3a on (A) mRNA and (B) protein level with 
AAV-Dnmt3a-shRNA in primary neuronal culture. (A) Dunnett’s post-hoc test after 
one-way ANOVA, **p < 0.01, in comparison with AAV-scrambled; (B) Student’s t-test, 
**p < 0.01, in comparison with AAV-scrambled; error bars indicate SEM; (A–B) n = 3. 
 
In the NAc of adult mice not sensitized to cocaine, bilateral injections of AAV-
Dnmt3a for 4 weeks decreased Dnmt3a expression, however, there was an 
increase in Dnmt3b mRNA (Figure 24A, Dnmt3a, t(12) = 4.498, ***p = 0.0007; 
Dnmt3b, t(12) = 3.280, **p = 0.0066). Dnmt1 expression did not change in the 
AAV-Dnmt3a group. AAV-Dnmt3a-mediated silencing in the NAc of saline-
injected mice also reduced the enzyme activity of DNMT (Figure 24B, 
t(10) = 8.961, ***p < 0.0001).  
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Figure 24. Dnmt3a silencing in the NAc of cocaine naïve mice decreases (A) Dnmt3a 
mRNA, increases Dnmt3b mRNA and reduces (B) DNMT activity. Student’s t-test, 
**p < 0.01, ***p < 0.001, in comparison with SAL+AAV-scrambled; error bars 
indicate SEM; (A–B) n = 6–8. 
 
 
3.2. AAV-shRNA-mediated silencing decreases Dnmt3a expression  
in the NAc at the initiation phase of cocaine-induced  
behavioral sensitization 
We first studied the role of Dnmt3a in the initiation phase of cocaine-induced 
behavioral sensitization in the NAc. The establishment of behavioral 
sensitization was verified on mice receiving cocaine intraperitoneally for 7 
consecutive days that increased locomotor activity in comparison with the 1st 
day of treatment (Fig. 25, treatment F (1,58) = 308.75, p < 0.0001; time  
F (1,58) = 16.33, p = 0.0002; interaction F (1,58) = 34.21, p < 0.0001; ***p < 0.001 




Figure 25. Repeated cocaine admin-
istration for 7 consecutive days induced 
behavioral sensitization in mice. Bon-
ferroni post hoc test after two-way 
ANOVA, ***p < 0.001 cocaine 1st vs. 7th 




A four-week period was included into the study design to silence Dnmt3a 
mRNA with AAV-Dnmt3a before repeated cocaine treatments (Fig. 26A). 
AAV-Dnmt3a decreased Dnmt3a expression in the saline-treated group (Fig. 
26B, #p < 0.001, AAV‐scrambled vs. AAV‐Dnmt3a shRNA) that was further 
decreased 24 h after acute and repeated cocaine treatment (**p < 0.01, 
compared with SAL group of AAV-scrambled injections). However, silencing 
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Dnmt3a before the initiation of behavioral sensitization also resulted in an 
induction of Dnmt1 expression after repeated cocaine treatments (Fig. 26C, 
*p < 0.05, ***p < 0.001 compared with SAL group of AAV-scrambled 
injections). Dnmt3b mRNA increased further after acute and repeated cocaine 
treatment in AAV-Dnmt3a mice (Fig. 26D, **p < 0.01, ***p < 0.001 compared 





Figure 26. Bilateral iNAc injection of AAV-Dnmt3a shRNA alters Dnmt mRNA after 
chronic cocaine administration. (A) Experimental design of Dnmt3a silencing in the 
NAc for 4 weeks before repeated cocaine administration for 7 days. (B) Dnmt3a 
expression reduced and (C) Dnmt1, (D) Dnmt3b mRNA increased in the NAc after mice 
received repeated cocaine injections. Bonferroni post hoc test after two-way ANOVA, 
*p < 0.05, **p < 0.01, ***p < 0.001 in comparison with SAL; #p < 0.01, ##p < 0.001, 
AAV-Scrambled-SAL vs AAV-Dnmt3a-SAL, error bars indicate SEM; n = 7–8. 
 
 
3.3. Dnmt3a silencing in the NAc increases the behavioral  
sensitization and decreases DNMT activity at the initiation phase 
Mice receiving repeated cocaine i.p. displayed increased locomotor activity 
after bilateral iNAc injections of AAV-Dnmt3a in comparison with AAV-
scrambled mice (Fig. 27A, treatment F (2,36) = 9.90, p = 0.0040; genotype  
F (1,36) = 6.48, p = 0.0154; interaction F (2,36) = 1.67, p = 0.2025; #p < 0.05 
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AAV‐Scrambled RC vs. AAV‐Dnmt3a RC). Bilateral iNAc injections of AAV-
Dnmt3a reduced DNMT enzyme activity further with acute and repeated 
cocaine treatments (Fig. 27B, #p < 0.001, AAV-scrambled vs. AAV-Dnmt3a). 
We correlated the decreased DNMT activity and increased locomotion of AAV-
injected mice that were administered cocaine for 7 days. Pearson’s correlation 
analysis showed a negative correlation between the DNMT activity and 
suggesting that DNMT activity, including DNMT3A, contributes to the 
development of behavioral sensitization (Fig. 27C, r = –0.06569, *p = 0.0107). 
 
 
Figure 27. Dnmt3a inhibition in the NAc increased (A) locomotor activity in the 
initiation phase of sensitization and decreased (B) DNMT activity levels 24 h after 
cocaine administration. (C) Correlation between DNMT activity and locomotion of RC 
group injected with AAV-Scrambled or AAV-Dnmt3a. (A) Bonferroni post hoc test 
after two-way ANOVA, #p < 0.05, AAV-Scrambled-SAL vs AAV-Dnmt3a-SAL. 
(B) Bonferroni post hoc test after two-way ANOVA, ***p < 0.001 in comparison with 
SAL; #p < 0.001, AAV-Scrambled-SAL vs AAV-Dnmt3a-SAL, error bars indicate 
SEM; (A–B) n = 7–8, (C) n = 14. 
 
 
3.4. Withdrawal from repeated cocaine alters DNMT expression and 
enzyme activity 
To study the effect of withdrawal from repeated cocaine on Dnmt mRNA and 
activity in the expression phase of behavioral sensitization, mice were with-
drawn from repeated cocaine administration for three weeks and injected with a 
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challenge dose of cocaine to manifest sensitization. A three-week abstinence 
period from chronic cocaine treatment induced locomotor activity (Fig. 28, 
main effect of group: F (3,27) = 46.14, p < 0.0001; ***p < 0.001 SAL vs. RC) and 
behavioral sensitization persisted after withdrawal and a challenge dose of 
cocaine in comparison with the AC and RS groups (#p < 0.001 AC vs. RC, RS 





Figure 28. A challenge dose of cocaine 
increases locomotor activity after with-
drawal from repeated cocaine for 7 
days. Bonferroni post hoc test after one-
way ANOVA, ***p < 0.001 in com-
parison with SAL; ##p < 0.001, AC vs 
RC and RS vs RC, error bars indicate 
SEM; n = 7. 
 
 
We found Dnmt1, Dnmt3a, Dnmt3b mRNA upregulated after withdrawal from 
repeated cocaine (Fig. 29A, main effect of group: Dnmt3a, F(3,27) = 6.755,  
p = 0.0015; Dnmt1, F(3,27) = 4.581, p = 0.0102; Dnmt3b, F(3,27) = 3.717, p = 0.0233, 
**p < 0.01, *p < 0.05 compared with SAL). The expression of Dnmt3a and 
Dnmt3b increased also in the RS mice, but not Dnmt1 mRNA that indicates 
their participation in cocaine associated cues during withdrawal. Cocaine also 
increased DNMT activity in all treatment groups (Fig. 29B, ***p < 0.001, 
compared with SAL) and a further induction in DNMT activity was detected 
with a cocaine challenge after repeated treatment (#p < 0.05 AC vs. RC; 
##p < 0.01 RS vs. RC). 
Figure 29. A challenge dose of cocaine increases (A) Dnmt1, Dnmt3a, Dnmt3b mRNA 
and (B) DNMT activity after withdrawal from repeated cocaine for 7 days. Bonferroni 
post hoc test after one-way ANOVA, *p < 0.05, **p < 0.01 in comparison with SAL;  




3.5. Effect of Dnmt3a silencing on the expression of cocaine-induced 
behavioral sensitization 
Our experimental design included 7 days of repeated cocaine treatment 
followed by iNAc AAV-Dnmt3a or AAV-scrambled injections and saline or 
cocaine challenge on the 35th day (Figure 30A). AAV infection was verified in 
the ventral striatum by mCherry protein expression encoded by the viral vector 
(Fig. 30B–C). TUJ1 (tubulin beta 3 class III, TUBB3) and mCherry double 
positive cells confirmed the neuronal transduction by AAV-Dnmt3a injected 
mice (Fig. 30D).  
 
 
Figure 30. Anatomical and cellular verification of AAV-Dnmt3a-shRNA-mCherry 
infection in mouse NAc. (A) Experimental design II of repeated cocaine treatments, fol-
lowed by Dnmt3a silencing in the NAc and a 4-week withdrawal before a challenge 
dose of cocaine administration. The (B–C) anatomical location and (D) infection of 
TUJ1+ (green) cells in the NAc by AAV-Dnmt3a-shRNA-mCherry (red) was verified 
immunohistochemically. DAPI (blue) labels nuclei. (B) Cartoon adapted from atlas of 
Mouse Brain in Stereotaxic Coordinates (Franklin and Paxinos, 2001), figure 21, 1.18 
mm Bregma. Scale bar: (C) 100 µm, (D) 5 µm. 
 
iNAc injections of AAV-Dnmt3a decreased Dnmt3a mRNA and increased 
Dnmt3b mRNA after withdrawal from repeated cocaine, while Dnmt1 
expression remained unaltered 2 h after the challenge dose (Figure 31A, Dnmt3a, 
t(26) = 5.328, ***p < 0.0001; Dnmt3b, t(26) = 2.484, *p = 0.0197 compared with 
the cocaine + AAV‐Scrambled group). AAV-Dnmt3a did not alter the loco-
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motor activity on the 35th day of behavioral sensitization (Fig. 31B, treatment 
F (1,65) = 0.21, p = 0.6464; time F (2,65) = 7.24, p = 0.0015; interaction F (2,65) = 
0.36, p = 0.6986). Finally, we detected no decrease in DNMT activity in the 
AAV-Dnmt3a mice in comparison with AAV-scrambled mice 2 h after cocaine 
challenge (Figure 31C, t(19) = 1.129, p = 0.2730). These results suggest that the 
selective silencing of Dnmt3a in the NAc does not alter DNMT activity and 




Figure 31. Dnmt3a inhibition in the NAc alters (A) Dnmt3a, Dnmt3b mRNA in the 
NAc, but does not change (B) locomotor activity or (C) DNMT activity in the NAc after 
the challenge dose of cocaine. (A) Student’s t-test, *p < 0.05, ***p < 0.001 in 
comparison with cocaine+AAV-scrambled, n = 13–15; (B) Bonferroni post hoc test 
after two-way ANOVA, *p < 0.05, **p < 0.01 in comparison with SAL, n = 13–15; 
(C) Student’s t-test, n = 10–11, error bars indicate SEM. 
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DISCUSSION 
1. Impact of DNA methylation on GR signaling  
in early life stress  
Despite increasing evidence of stress-induced changes in DNA methylation, the 
role of DNMT in stress response remains poorly understood. GR signaling is 
one possible pathway by which stress may modulate DNA methylation and 
further downstream events on specific genes. The epigenetic impact of early life 
stress has been studied in many signaling pathways, including HPA axis, BDNF, 
GABA, glutamate, estrogen, oxytocin signaling (Jawahar et al., 2015). HPA 
axis pathway has largely remained in the focus due to its effect on physiological 
and behavioral response to stressful events. 
Individuals with a history of childhood abuse who committed suicide had 
altered DNA methylation within the promoters 1B, 1C, and 1F of GR compared 
with nonabused suicides and healthy controls (Labonte et al., 2012; McGowan 
et al., 2009). These changes resulted in lower expression of the respective tran-
scripts of GR that may affect the GRE-regulated gene expression e.g. Dnmt3b. 
Similar findings in the alterations of GR have been reported in association of 
different features of child abuse in individuals with depressive disorders and 
these changes seem to be specific to early life adversity (Bagot et al., 2014). GR 
promoter methylation status seems to be specific to the paradigm as no 
alterations were found with the maternal separation model at PND21 (Daniels et 
al., 2009). GR mRNA remained unchanged in our study and has close-to-adult 
expression level (Kalinyak et al., 1989). We found that genomic signaling of 
GR increases Dnmt3b expression after maternal separation in the PFC. DNMT3A 
and DNMT3B cooperate to methylate the genome in embryos. However, 
DNMT3B also has non-redundant roles in embryonic development and 
DNMT3A can deposit non-CpG methylation in neurons after birth showing 
unique roles for either enzymes during development (Greenberg and Bourc’his, 
2019). Therefore, we speculate that Dnmt3b induction after early life stress to 
alter the methylation pattern of specific genes may be different from the target 
genes of Dnmt3a. 
The outcome of methylation patterns after early adverse events may have 
several layers of regulation. The study from Labonte and colleagues also 
showed a complex pattern of methylation across other CpG sites in the GR gene 
of abused suicide completers that did not result in transcriptional alterations in 
comparison with controls (Labonte et al., 2012). Differential methylation of 1B, 
1C, and 1F was detected in non-abused suicides that did not result in a change 
of GR expression (Labonte et al., 2012; McGowan et al., 2009). The relevance 
of these transcriptionally silent epigenetic modifications remains unknown, but 
it has been speculated to mediate an increase in speed of regulatory responses to 
activity or environmental cues (Burns et al., 2018). A term “epigenetic priming” 
is referred to as permanent changes in neuronal chromatin structure that govern 
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silent dysregulation of transcription that remain silent in NAc until triggered by 
re-exposure to the drug or to drug cues (Mews et al., 2018). Epigenetic priming 
or desensitization affects genes that regulate AMPA or NMDA receptor levels 
among other synaptic and neural-signaling proteins to induce plasticity in the 
synapse and the neural circuit (Mews et al., 2018). A set of genes were distin-
guished that are up- or downregulated by cocaine re-exposure and not cocaine 
cue alone after abstinence from repeated cocaine and the authors hypothesized 
that these genes are primed or desensitized during withdrawal and activated or 
repressed by drug re-exposure (Mews et al., 2018). 
Dnmt3b is linked to de novo methylation; its role has been less studied than 
Dnmt3a. Dnmt3b expression is induced in the intestinal epithelium to function-
ally compensate Dnmt1-deficient tissue (Elliott et al., 2016). The expression of 
Dnmt3b in the nervous system decreases dramatically after birth to very low 
mRNA levels (Yue et al., 2014). We speculate that the induction of Dnmt3b 
after MS may be a stress-related neuroadaptation to maintain or alter the 
methylation patterns in specific genes (Paper I). However, further studies could 
elucidate the interaction partners of GR that induce Dnmt3b and Dnmt3a 
expression after early life stress. Given the complexity of PFC, Dnmt3a and 
Dnmt3b may be differentially regulated in this region. Knockdown of Dnmt3a 
in the PFC displayed an anxiogenic phenotype, while the overexpression of 
Dnmt3a induced an anxiolytic effect (Elliott et al., 2016). Therefore, the authors 
suggested that Dnmt3a-mediated methylation patterns in the PFC may mediate 
chronic stress-induced anxiety behavior (Elliott et al., 2016).  
Mifepristone abolishes the CORT-induced increase in Dnmt expression 
indicating GR involvement in the transcriptional regulation of Dnmt1, Dnmt3a 
and Dnmt3b after CORT exposure (Paper I). A supersaturating dose of CORT 
was used to study the mechanism in primary neurons. Astrocytes are more 
sensitive to GR stimulation than neurons (Slezak et al., 2013); the lack of glial 
cells in our primary cultures may have reduced the CORT-induced effect on 
Dnmt3a and Dnmt3b in comparison with the upregulation seen in the PFC 
(Paper I). GR binds to the GRE-containing regions in Dnmt3a in the PFC in all 
rearing conditions (Paper I). These results suggest that genomic signaling of GR 
regulates Dnmt expression. GR signaling causes increased chromatin access-
ibility in many genomic sites that enables other steroid receptors such as 
estrogen receptor to bind at the same site (Wiley et al., 2016). Although, we did 
not study ESR1 binding levels, maternal behavior is known to affect gene-
specific gene methylation, including Esr1 in female rodents (Champagne et al., 
2006), thus the causal relationship between Dnmt3a induction and Esr1 regulation 
in male rats after early life stress remains to be clarified. Alternatively, since GR 
immunoprecipitation levels remained unaltered in MS180 animals, other tran-
scription factor response elements may have greater influence on Dnmt3a 
mRNA increase after maternal separation. We speculate that genomic signaling 
of GR may also be involved in the transcriptional regulation of Dnmt3a and 
Dnmt3b in the NAc after maternal separation (Anier et al., 2014). 
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Early life stress-associated changes in epigenetic modifiers in the brain may 
be region and age specific. Dnmt1, Dnmt3a and Dnmt3b increases in other brain 
regions after maternal separation (Anier et al., 2014; Boku et al., 2015; Park et 
al., 2018). Dnmt3a expression is increased by MS (Anier et al., 2014) and by 
chronic social stress (LaPlant et al., 2010) in the NAc, an key region in reward-
associated behavior. Dnmt1 expression, that is representative of maintenance 
methylation, is affected after MS in the hippocampal tissue (Park et al., 2018), 
as well as in neural precursor cells (Boku et al., 2015). In the hippocampus, MS 
prevents the neural progenitors to differentiate into neurons that was reversed 
by a DNMT inhibitor (Boku et al., 2015). In the PFC at PND15, maternal 
separation increased Dnmt1, Dnmt3a, Dnmt3b expression (Paper I). Maltreat-
ment affected DNA methylation in the loci of Dnmt1, Dnmt3a, Mecp2 and 
Gadd45b (a protein required for activity-induced DNA demethylation) in an 
age-specific manner. Namely, alterations in the expression of these genes did 
not occur in the second week after birth, but were present in the adult PFC 
(Blaze and Roth, 2013). Changes in the enzyme activity and global methylation 
levels in the PFC are also age-dependent. MS does not alter global methylation 
(Anier et al., 2014; McCoy et al., 2016) nor DNMT activity (Ignácio et al., 
2017) in the adult PFC, but DNMT activity was increased at PND15 in the PFC 
(Paper I). 
The activity of the HPA axis is also regulated intracellularly by Fkbp5. 
FKBP5 is a co-chaperone of the GR complex that decreases GR binding affinity 
to glucocorticoids. Fkbp5 is affected by the DNA methylation-demethylation 
machinery in HPA dysregulation. Childhood stress-related demethylation of a 
GRE in intron 7 of FKBP5 in the context of GR stimulation results in increased 
expression of FKBP5 (Klengel et al., 2013). The authors speculated that lower 
expression of FKBP5 leads to reduced negative feedback and hyperactivity of 
the HPA axis. This particular epigenetic modification only emerges in early life, 
suggesting that the functioning of certain GREs is restricted to this period in 
life. The two GREs in rat Dnmt3b promoter suggest responsiveness to GR 
stimulation in early life, although their functionality in adulthood is unclear 
(Paper I). It would be important to ascertain in future studies which GREs or 
their modifications in Dnmt genes are restricted to early life. 
The activity-regulated Dnmt3a2 transcript has been previously linked with 
neuronal activity (Oliveira et al., 2012) and the regulation of drug cue memory 
(Cannella et al., 2018). Cannella et al showed that silencing of Dnmt3a2 in the 
NAc shell reduced the cue-induced cocaine seeking, thus Dnmt3a2 promotes 
cocaine seeking. Dnmt3a2 also affected immediate early genes that participate 
in memory consolidation. The authors suggest that reduced levels of Dnmt3a2 
mRNA allow for a less permissive genomic state to strengthen drug-associated 
memories. Maternal separation can influence activity-regulated transcriptional 
activation and we showed that Dnmt3a2 transcript is affected by maternal 
separation in the PFC (Paper I). Future studies can elucidate the role of Dnmt3a2 
transcript in stress-induced adaptations on memory function. Interestingly, it 
was recently proposed that activity-regulated gene expression in early life can 
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be mediated in a Dnmt3a-dependent manner and the phenomenon is long-
lasting (Stroud et al., 2017). Decreased DNMT3A binding along with lower 
levels of non-CG methylation in the immediate early genes can be detected 8 
weeks after the early activity-dependent experience. However, the causality of 
non-CpG methylation and gene expression was not assessed in this study, thus 
the impact on the neuronal function by experience-dependent changes on non-
CpG methylation remains to be clarified.  
It is clear that early life stress-induced changes in DNA methylation do not 
occur only in a subset of candidate genes e.g. GR. Genome-wide studies in 
animals mapping alterations in DNA methylation after stress are beginning to 
emerge. Most recent genome-wide studies show that early life stress impacted 
methylation patterns in species and sex dependent manner (Burns et al., 2018). 
McCoy and colleagues found global hypermethylation in the hippocampus of 
male rats exposed to maternal separation and clusters of hypomethylation at 
specific genomic loci (McCoy et al., 2016). The biological pathways with 
altered DNA methylation included cell proliferation, insulin signaling, axonal 
guidance, tyrosine kinase signaling, synaptogenesis and synaptic transmission. 
However, the resilient phenotype they observed in MS rats with reduced levels 
of anxiety- and depressive-like behavior is contrary to what is normally observed 
in MS exposed rodents. Thus, caution should be taken in interpreting the con-
sequences of specific epigenomic alterations within different genomic back-
grounds, a stress reactive rat strain in this case. Interestingly, recent evidence 
has been provided of differential epigenetic programming of individuals with 
history of child abuse in neuronal cells and oligodendrocytes (Burns et al., 
2018). The functional impact of differentially methylated loci is yet unclear due 
to variety of methods used and multiple individual factors, such as cell type, 
genetic background, species, sex and stress-resilient phenotype that interact 
with early life stress. Therefore, candidate gene approaches still are a crucial 




2. The cross-tissue alterations in cocaine-induced  
DNA methylation modifiers and the role of DNMT3A  
in repeated cocaine administration and withdrawal  
2.1. The behavioral response to cocaine action 
The studies with pharmacological manipulations on DNA methylation have 
shown that the interaction between DNA methylation and the behavioral response 
to cocaine action is complex and involve region and abstinence specificity, the 
latter will be discussed in the following chapter. Methyl supplementation, such 
as methionine and SAM provide the methyl group substrates to DNMT 
enzymes that could increase DNA methylation (Zeisel, 2009). In the following 
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studies, behavior was assessed up to 24 h after last cocaine administration. 
Systemic administration of methyl supplementation increased sensitization to 
cocaine (Anier et al., 2013). Conversely, intracerebroventricular injections of 
zebularine, a DNMT inhibitor, delayed cocaine-induced behavioral sensitization 
(Anier et al., 2010). However, in the NAc, local Dnmt3a overexpression 
decreases cocaine seeking behavior and conversely, DNMT inhibition increases 
cocaine seeking and behavioral sensitization (LaPlant et al., 2010). Therefore, 
the decrease or increase in behavioral response to cocaine depends on the region 
where DNA methylation is altered. Pharmacological manipulations of DNA 
methylation in the VTA have not been studied in cocaine action, but circuit-
specific (NAc vs. VTA) epigenetic alterations seem to differ between a natural 
reward and cocaine reward in the NAc (Day et al., 2013; Massart et al., 2015). 
The work from Wright and colleagues showed no effect of methyl supple-
mentation on the acute locomotor response to cocaine, although Dnmt3a and 
Dnmt3b mRNA was specifically increased in the NAc, which suggests that the 
role of DNA methylation in the NAc becomes more important as cocaine 
dependence develops (Wright et al., 2015). 
Dnmt3a is considered to have a prominent role in the NAc during cocaine 
abuse. LaPlant and colleagues demonstrated a negative regulation of Dnmt3a in 
cocaine seeking behavior as described above (LaPlant et al., 2010). In addition, 
the authors used Cre-mediated knockdown of Dnmt3a in the NAc that also 
increased cocaine seeking behavior, which is in line with the results obtained 
with a DNMT inhibitor, while Dnmt1 knockdown had no effect on cocaine 
seeking behavior (LaPlant et al., 2010). Silencing Dnmt3a in the NAc enhanced 
the behavioral sensitization in the induction phase and also showed a negative 
correlation between Dnmt3a expression and reward behavior (Paper III). Our 
results with the behavioral sensitization model add evidence to the hypothesis 
that increased DNA methylation impairs rewarding signaling in the NAc at the 
binge/intoxication stage, although, as seen in the aforementioned study, this 
mechanism may have the side-effect of increasing depressive-like symptoms. 
Dnmt1 and Dnmt3a mRNA were upregulated both in AC and RC groups in 
the NAc (Paper II and III), thus their role is not necessarily associated with 
withdrawal and sensitization. Dnmt3a could play a role in behavioral sensitiza-
tion from the acquisition phase and upon silencing Dnmt3a expression before 
repeated cocaine injections, sensitization increased as discussed above (Paper 
III). We speculate that Dnmt3b may have a unique role in the withdrawal phase, 
since acute cocaine does not affect its expression (Paper II and III). Dnmt3b was 
found downregulated in the hippocampus of rats withdrawn from cocaine self-







2.2. Gene specific alterations in DNA methylation during  
withdrawal from repeated cocaine  
The abovementioned studies (Anier et al., 2010; LaPlant et al., 2010) are limited 
on two aspects. Firstly, a withdrawal period was not included in the design of 
these studies to investigate the effect of abstinence on DNA methylation. 
Secondly, none of these studies used a genome-wide analysis of methylation. 
Global levels of 5-mC and the methylation status and expression of some genes 
were assessed. These two limitations were addressed in the study by Massart 
and colleagues (Massart et al., 2015). The “incubation of craving” method in the 
self-administration model was used with treatments of RG108 or SAM to 
measure the genome-wide DNA methylation and the gene expression in the 
NAc after a short (1 day) or long (30 days) period of withdrawal. Their analysis 
of functionally related pathways with differential promoter methylation during 
long withdrawal period highlighted the following pathways: cancer, morphology 
of cells and ephrin receptor signaling, neurotrophin signaling, GR signaling, 
synaptic long-term depression. The members involved in these pathways (e.g. 
GR) have been associated previously with motivation to self-administer cocaine 
(Deroche-Gamonet et al., 2003). Different directions of the methylation status 
over time were also examined by Massart and colleagues (Massart et al., 2015). 
Some methylation marks remained stable (e.g. Creb1) over prolonged with-
drawal. Other DNA methylation alterations were enhanced during withdrawal, 
becoming more hypermethylated or hypomethylated while abstinence progressed 
(e.g. Dnmt1, Dnmt3a, Dnmt3b, GR, Grin1). Our study on Grin1 3’ UTR methyla-
tion mark indicated an increase in hypermethylation after a long period of with-
drawal (unpublished results, Fig. 20B, AC vs RC), although the methylation site 
may be species specific for mouse as no alterations downstream of the tran-
scription start site were seen in the rat model (Massart et al., 2015). Interestingly, 
cue-induced cocaine seeking generally reversed alterations in methylation 
triggered by abstinence (Massart et al., 2015), some examples of such genes are 
involved in glutamate signaling (Gad1, Grm3). We suggest that Grin1 may also 
be involved in cue-induced processes after a withdrawal period in mice.  
Massart et al reasoned that RG108 blocks the “incubated” or heightened 
cocaine craving by demethylating target genes. Esr1 was hypothesized to be one 
of critical genes that is affected by DNA methylation changes and could alter 
the incubation of craving. In fact, RG108 injections to the NAc resulted in 
increased Esr1 expression and decreased methylation at its promoter after 30 
day withdrawal from repeated cocaine in comparison with the opposite effects 
of SAM injections (Massart et al., 2015). A previous study shows that Esr1 
knock-out mice display enhanced cocaine sensitization and a trend toward 
increased cocaine seeking in the place preference paradigm (Lasek et al., 2011). 
In addition, estrogen contributes to cocaine-induced behaviors both in females 
and males (Lasek et al., 2011). Thus, conversely, an ESR1 agonist caused a 
dramatic decrease in cue-induced cocaine seeking behavior after a withdrawal 
period (Massart et al., 2015). The data presented in our publications confirm the 
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methylation and expression changes of Esr1 induced by withdrawal from 
repeated cocaine and a challenge dose in comparison with a saline group (Paper 
II). Interestingly, the alteration in methylation and hydroxymethylation at the 
Esr1 promoter occurs in the cue-induced RS group that did not receive cocaine 
without changes in expression (Paper II). Transcriptionally silent DNA modi-
fications in promoters have been described also in humans in a stress-related 
context that will be further discussed below (Labonte et al., 2012). 
 
 
2.3. Cocaine-induced changes in DNA methylation across tissues 
The relevance of DNA methylation changes in peripheral tissues for neuro-
psychiatric diseases has recently gained much attention, because DNA methyla-
tion patterns are cell-type specific. However, an increasing number of studies 
show a differential methylation that correlates across brain and peripheral tissues 
within subjects (Lax and Szyf, 2018). In the field of addiction, the human 
studies performed so far have been on alcohol abusers (Lax and Szyf, 2018). In 
cocaine abuse, our study (Paper II) presents evidence on the dynamic alterations 
in Dnmt genes across three tissues in mice. Acute cocaine treatment decreased 
Dnmt1, Dnmt3a mRNA levels in the NAc and PBC, whereas 24 h later, Dnmt3a 
mRNA and DNMT enzyme activity levels were upregulated in both tissues 
(Paper II). Dopamine transporter (DAT) is expressed in various peripheral 
immune cells and cocaine blocks the DAT-dependent uptake of dopamine in 
lymphocytes, suggesting that the DAT present in lymphocytes functions similarly 
as the DAT expressed in the CNS (Mackie et al., 2018). Cocaine as well as 
procaine has a local anesthetic effect. Functional voltage-gated sodium channels 
are expressed in various immune cells and erythrocytes (Black and Waxman, 
2013). Acute procaine injections resulted in an opposite effect on Dnmt3a 
expression in PBC (Paper II). The contrasting outcomes of cocaine and procaine 
on Dnmt3a mRNA may be caused by different pharmacokinetic properties; 
procaine (half-life 7.7 min in human plasma) has a shorter duration of action in 
comparison with cocaine (half life 1 h), suggesting that voltage-gated sodium 
channels may be involved in the effect of cocaine on Dnmt expression in PBC. 
On gene specific level, the decrease in the expression of Esr1 correlated 
across mouse NAc and PBC after an abstinence period and a cocaine challenge 
(Paper II). Furthermore, hydroxymethylation levels were induced at the Esr1 
promoter that correlated across tissues in mice exposed to cocaine associated cues 
(RS, Paper II). Cross-tissue studies on a large cohort of alcohol abusers have 
found few differentially methylated genes that have been replicated (Lax and 
Szyf, 2018). However, there is mainly a need for human studies on drug abusers 
that assess the treatment outcome of DNA methylation inhibitors and the effect 
on drug relapse. Additionally, it may be beneficial to screen for differentially 
methylated loci as biomarkers in recreational drug users that would aid in 
identifying the individuals at high risk for developing drug abuse disorder. 
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In our study we chose Cer as a reference tissue to study epigenetic changes 
in the mesolimbic dopaminergic pathway (NAc). However, withdrawal from 
repeated cocaine also increased in Dnmt1, Dnmt3a, Dnmt3b mRNA in the Cer 
(Paper II). Recently it was shown that different subsets of granule cells respond 
to reward delivery, anticipation and omission (Wagner et al., 2017). Thus, the 
question arises of how is reward related information contributing to the 
cerebellar function. Classical models postulate that granule cells are activated 
with sensorimotor signals. The fact that granule cells are able to integrate 
sensorimotor information as well as reward-omission and reward-anticipation 
signals indicates cerebellar involvement in cognitive processing. Although the 
input pathways that activate these populations of neurons in the reward context 
are currently unknown, we speculate that DNA methylation may participate in 
the cocaine-induced changes in the Cer. We noted that Dntm3b expression may 
be associated with withdrawal in the Cer (Paper II), thus Dnmt3b would be an 
interesting candidate to study in the withdrawal phase from repeated cocaine in 
the Cer.  
DNA methylation is a source of new type of biomarkers. Levels of DNA 
methylation at specific CpG locations and inter-individual variation in DNA 
methylation are known to vary across tissues, especially due to the cellular 
heterogeneity (Bakulski et al., 2016). Furthermore, epigenetic modifications 
vary also between different cell types within the same tissue (Mo et al., 2015b). 
However, the expression of Dnmt as well as their enzyme activity was more 
pronounced in NAc than in other tissues outside the mesolimbic dopaminergic 
system (Paper II). We also noted an increase in DNMT activity in the NAc of 
RC mice in comparison with AC group 24 hours after cocaine challenge, sug-
gesting an association with withdrawal (Paper II, Fig. 7; Paper III, Fig. 5). 
Although the cell type specific alterations in DNA methylation in the Cer and in 
PBC needs further study, DNMT activity seems a promising candidate to 
identify cocaine exposure across tissues after the drug has been metabolized. 
The disease-related changes in other epigenetic protein levels (e.g. histone 
deacetylases), as well as enzyme activity are currently under study in neuro-
degenerative disorders (Sartor, 2019). 
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SUMMARY AND CONCLUSIONS 
The biochemical evidence presented in this dissertation shows that a stress-
related neuroadaptation occurs during maternal separation inducing DNA 
methylation in the PFC. Our data suggests that genomic signaling of GR con-
tributes to the regulation of DNA methylation-mediated neural (mal)adaptations 
during early life stress. DNA methylation-induced maladaptations (may sensitize 
the stress responsivity that) can underlie the predisposition to cocaine abuse. 
In the expression and abstinence of cocaine abuse, chronic cocaine increased 
DNMT activity in the NAc. Dnmt1 and Dnmt3a contribute to repeated cocaine-
induced cellular adaptations across tissues. Dnmt3a silencing increased beha-
vioral sensitization in the induction phase, indicating that DNMT3A-mediated 
methylation inhibits reward behavior from the acquisition of behavioral sensit-
ization. 
 
The results suggest the following conclusions: 
1. Our study showed that MS leads to the stimulation of the glucocorticoid 
receptor genomic pathway and thus could be involved in the regulation of 
DNA methylation in the brain. MS increased Dnmt1, Dnmt3a, Dnmt3b 
expression and DNMT activity suggesting that early life stress can affect 
DNA methylation in the PFC and the increased DNMT activity in the PFC 
may be age-specific. Results with GR-antagonist on primary neurons and 
increased GR binding at Dnmt3b promoter suggest that Dnmt3b is regulated 
by genomic signaling of GR after early life stress, although the specific regu-
latory elements remain to be determined. Genomic signaling of GR also may 
regulate Dnmt3a in the PFC and affect the activity-regulated transcriptional 
activation of Dnmt3a. The results of this study suggest that early life stress-
induced changes in DNMT enzyme activity may lead to persistent changes 
in gene expression that predisposes to cocaine abuse. 
 
2. Acute cocaine increases Dnmt1 and Dnmt3a expression across tissues that 
are specific for psychostimulant abuse and non-specific tissues. The effect of 
acute cocaine and acute procaine on Dnmt3a expression suggests that 
Dnmt3a regulation involves voltage-gated sodium channels in PBC. Repeated 
cocaine administration increased DNMT activity in behavioral sensitization 
expression phase and in abstinence, therefore DNMT activity is involved in 
both the expression phase and abstinence. Both acute and chronic cocaine 
induce DNMT enzyme activity in NAc and PBC that support the idea of a 
biomarker that correlates across tissues. Acute and chronic cocaine have 
opposing effects on the methylation of both Esr1 and Grin1 in the NAc. Our 
study showed that some cocaine-induced changes on Dnmt3a, Dnmt3b, 




3. Our study suggests a role for Dnmt3a in the acquisition phase of cocaine-
induced sensitization. Silencing of Dnmt3a in the NAc reduced DNMT 
enzyme activity and repeated cocaine administration increased behavioral 
sensitization in comparison with control group mice, therefore Dnmt3a has 
an important role in the acquisition phase of behavioral sensitization. 
However, Dnmt3a silencing in NAc did not affect behavioral sensitization in 
the abstinence phase. Dnmt3b induction during Dnmt3a silencing indicated 
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SUMMARY IN ESTONIAN 
DNA metülatsiooni roll kokaiini ravimsõltuvuse väljakujunemises, 
sõltuvuse avaldumises ja abstinentsis 
Ravimsõltuvus on ajuhaigus, milles psühhoaktiivne aine kutsub esile füüsilisi, 
psüühilisi probleeme, sotsiaalse funktsiooni puudujääki või töövõimekuse halve-
nemist. Uuringud näitavad, et ligikaudu pooled psühhostimulaatorite (näiteks 
kokaiin, amfetamiin) regulaarsetest tarbijatest muutuvad ravimsõltuvateks. Ini-
mestel on erinev riskitase psühhostimulaatoritest sõltuvuse tekkeks, nende 
riskide uurimine aitab paremini mõista ravimsõltuvuse mehhanisme. Hiljuti 
avaldatud teadustööd näitavad, et nii geneetilised tegurid kui ka keskkond (näiteks 
traumaatilised läbielamised varajases eas) mõjutavad indiviidi ravimsõltuvuse 
tekkeriski. Varasemad uuringud on näidanud, et psühhostimulandid põhjustavad 
muutusi geeniekspressioonis, mida osaliselt vahendavad epigeneetilised mehha-
nismid sh. DNA metülatsioon. Käesoleva doktoritöö eesmärk oli uurida, nii 
katseloomade käitumise kui ka molekulaarsel tasemel, kas kokaiini poolt põh-
justatud DNA metülatsiooni muutused võivad olla ravimsõltuvuse indviduaalse 
tundlikkuse, sõltuvuse avaldumise ja abstinentsi üheks mehhanismiks. Samuti 
oli doktoritöö eesmärgiks hinnata, kas ravimsõltuvuse riskitegur stress mõjutab 
epigeneetilisi protsesse ajus. 
DNA metülatsioon on epigeneetiline mehhanism rakus, mis vahendab geeni-
ekspressiooni muutusi vastusena keskkonna- ja arengust tingitud mõjuritele. 
DNA metüleerimist viivad läbi ensüümid DNA metüültransferaasid (DNMT), 
mis on vajalikud imetajate arenguks. Mutatsioone DNMT3A geenis seostatakse 
Tatton-Brown-Rahman sündroomi ja autismiga. DNMT1 geeni mutatsioone on 
seostatud neuroloogiliste ning psühhiaatriliste häiretega sh tserebellaarataksia, 
sensorineuraalne kuulmislangus, narkolepsia, dementsus jt. Dnmt3a-puudu-
likkusega hiired, kellel see geen on väljalülitatud, surevad varajases eas peale 
sündi. Ka Dnmt1- ja Dnmt3b-puudulikkusega hiired ei ole elujõulised. Vara-
semad uuringud näitasid, et psühhostimulantide manustamisel algatatud DNA 
metüleerimise ja geeniekspressiooni muutused võivad luua olukorra, mis soo-
dustavad nii ravimsõltuvuse teket kui ka püsimist. Farmakoloogiliste ja käitumis-
katsete andmed viitavad, et Dnmt3a võib olla kõige olulisem DNA metüül-
transferaas psühhostimulantide sõltuvuses.  
Dissertatsiooni I artikli tulemused näitasid, et maternaalne separatsioon 
(varajase eluea stressi mudel) põhjustab glükokortikoidi retseptori rakusisese (ge-
noomse) signaalraja stimulatsiooni ja võib osaleda DNA metülatsiooni regulat-
sioonis ajus. Meie uuringud näitasid, et maternaalne separatsioon suurendab 
Dnmt1, Dnmt3a, Dnmt3b ekspressiooni ja DNMT ensümaatilist aktiivsust rottide 
prefrontaalses korteksis. Promootorala uuringud näitasid, et GR genoomne sig-
naalirada reguleerib Dnmt3b geeniekspressiooni, ent konkreetsed regulatooralad 
on kindlaksmääramata. Meie katsed näitasid, et glükokortikoidi retseptori 
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genoomne signaalirada võib mõjutada ka Dnmt3a ekspressiooni ning neuraal-
sest aktiivsusest-sõltuvat Dnmt3a transkriptsiooni. Nende uuringute tulemustest 
võib järeldada, et varajase eluea stressist põhjustatud DNMTde ensümaatilise 
aktiivsuse muutused ajus võivad omakorda viia püsivate muutusteni geeni-
ekspressioonis, mis võivad suurendada kokaiini tundlikkust. 
Dissertatsiooni II ja III artiklis uurisime DNMTde rolli kokaiini korduval 
manustamisel kasutades hiirte käitumusliku sensitisatsiooni mudelit. Korduv 
kokaiini manustamine põhjustab katseloomadel võimendunud käitumisvastuse, 
mida nimetatakse käitumuslikuks sensitisatsiooniks. See käitumuslik fenomen 
modelleerib sõltuvuskäitumist ja kokaiini psühhootilisi komplikatsioone ini-
mesel. Hiirtel eristatakse käitumusliku sensitisatsiooni kujunemisfaasi ning 
väljendumisfaasi. Käitumusliku sensitisatsiooniga on seostatud aju sarrustus-
piirkonnad, näiteks naalduv tuum (nucleus accumbens) ja prefrontaalkorteks.  
Meie uuringud näitasid, et korduva kokaiini manustamine hiirtele suurendab 
DNMTde ensümaatilist aktiivsust käitumusliku sensitisatsiooni väljendumis-
faasis ja abstinentsi perioodil, seega on nii käitumusliku sensitisatsiooni väljen-
dumisfaas kui ka abstinents seotud DNMT ensümaatilise aktiivsusega naalduvas 
tuumas. Meie katsete tulemused selgitasid, akuutne ja korduva kokaiini manus-
tamine hiirtele põhjustas Dnmt1 ning Dnmt3a geeniekspressiooni ning DNMT 
aktiivsuse suurenemise nii naalduvas tuumas, kui ka vererakkudes (täpsemalt 
leukotsüütides). Prokaiini (kokaiinisarnane aine) mõju vererakkudele viitab, et 
Dnmt3a ekspressiooni regulatsioon leukotsüütides võib olla seotud pingest-
sõltuvate naatriumkanalitega. Nende uuringute tulemused näitasid, et osad 
kokaiinist tingitud DNMTde muutused aju naalduvas tuumas on sarnased 
muutustele katseloomade leukotsüütides. 
Dissertatsiooni III artiklis vaigistasime hiire Dnmt3a geeni naalduvas tuumas, 
mille tulemusel vähenes DNMT ensümaatiline aktiivsus ja korduv kokaiini 
manustamine põhjustas käitumusliku sensitisatsiooni suurenemise võrreldes 
kontrollgrupi hiirtega, viidates Dnmt3a olulisele rollile käitumisliku sensitisat-
siooni kujunemisfaasis. Samas ei mõjutanud Dnmt3a geeni vaigistamine naaldu-
vas tuumas käitumusliku sensitisatsiooni abstinentsi perioodil. Meie tulemused 
viitasid, et Dnmt3b geeni ekspressiooni suurenemine naalduvas tuumas võis 
kompenseerida Dnmt3a vaigistamise efekti.  
Kokkuvõttes annavad antud dissertatsiooni aluseks olevad artiklid meile uusi 
teadmisi ravimsõltuvuse molekulaarsete mehhanismide kohta ja näitavad uusi 
võimalusi ravimsõltuvuse ravi alasteks uuringuteks.  
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